(ROOT
  (S
    (S
      (NP
        (NP (JJ Differential) (JJ clinical) (NN efficacy))
        (PP (IN of)
          (NP
            (NP (JJ anti-CD4) (JJ monoclonal) (NNS antibodies))
            (PP (IN in)
              (NP (NN rat) (NN adjuvant) (NN arthritis))))))
      (VP (VBZ is)
        (VP (VBN paralleled)
          (PP (IN by)
            (NP
              (NP (NN differential) (NN influence))
              (PP (IN on)
                (NP (JJ NF-κB) (JJ binding) (NN activity))))))))
    (CC and)
    (S
      (NP
        (NP (JJ TNF-α) (NN secretion))
        (PP (IN of)
          (NP
            (NP (NNP T) (NNP cells) (NNP Abstract))
            (NP (DT The) (NN aim))))
        (PP (IN of)
          (NP (DT this) (NN study))))
      (VP (VBD was)
        (UCP
          (S
            (VP (TO to)
              (VP (VB analyze)
                (NP
                  (NP (DT the) (NN differential) (NNS effects))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (CD three) (JJ anti-CD4) (JJ monoclonal) (NNS antibodies))
                        (PRN (-LRB- -LRB-)
                          (NP (NNS mAbs))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (PP (IN with)
                          (NP (JJ distinct) (NN epitope) (NNS specifities)))
                        (-RRB- -RRB-)))))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NN rat) (NN adjuvant) (NN arthritis))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP AA))
                          (-RRB- -RRB-)))))))))
          (CC and)
          (PP (IN on)
            (NP (JJ T-cell) (NN function)
              (CC and)
              (NN signal) (NN transduction))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Rat) (NNP AA))
    (VP (VBD was)
      (ADVP (RB preventively))
      (VP (VBN treated)
        (PP (IN by)
          (NP
            (NP (JJ intraperitoneal) (NN injection))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NN W3/25))
                (, ,)
                (NP (NNP OX35))
                (, ,)
                (CC and)
                (NP (NNP RIB5/2))
                (PRN (-LRB- -LRB-)
                  (PP (IN on)
                    (NP
                      (NP
                        (NP (NNS days))
                        (NP (CD -1) (, ,) (NN 0) (, ,) (CD 3) (, ,)
                          (CC and)
                          (CD 6))
                        (, ,)
                        (ADVP (RB i.e.)
                          (NP (CD 1) (NN day))
                          (PP (IN before)
                            (NP (NNP AA) (NN induction)))))
                      (, ,)
                      (UCP
                        (PP (IN on)
                          (NP
                            (NP (DT the) (NN day))
                            (PP (IN of)
                              (NP (JJ induction) (JJ -LSB-) (NN day) (NNP 0) (NNP -RSB-)))))
                        (, ,)
                        (CC and)
                        (ADVP (RB thereafter)))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NNS effects))
        (PP
          (PP (IN on)
            (NP
              (NP
                (NP (NNP T-cell) (NNP reactivity))
                (PP (IN in)
                  (NP (NN vivo))))
              (PRN (-LRB- -LRB-)
                (NP (JJ delayed-type) (NN hypersensitivity))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (JJ ex) (NN vivo))
                (PRN (-LRB- -LRB-)
                  (NP (JJ ConA-induced) (NN proliferation))
                  (-RRB- -RRB-)))
              (, ,)))
          (CC and)
          (PP (IN in)
            (NP (NNP vitro)))))
      (PRN (-LRB- -LRB-)
        (NP (JJ mixed) (NN lymphocyte) (NN culture))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN assessed)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The)
        (ADJP (IN in) (NN vitro))
        (NNS effects))
      (PP (IN of)
        (NP
          (NP (JJ anti-CD4) (NN preincubation))
          (PP (IN on)
            (NP
              (NP
                (NP (JJ T-cell) (NN receptor))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TCR))
                  (-RRB- -RRB-)))
              (PRN (: /)
                (ADVP (RB CD3-induced))
                (NP (JJ cytokine) (NN production)
                  (CC and)
                  (NN signal) (NN transduction))))))))
    (VP (VBD were)
      (VP
        (ADVP (RB also))
        (VBN analyzed)))
    (. .)))

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (JJ preventive) (NN treatment))
          (PP (IN with)
            (NP (NNP OX35)
              (CC and)
              (NNP W3/25))))
        (ADVP (RB significantly))
        (VP (VBD ameliorated)
          (NP (NNP AA))
          (PP (IN from)
            (NP (DT the) (NN onset))))))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP RIB5/2))))
    (VP
      (VP
        (ADVP (RB even))
        (VBD accelerated)
        (NP
          (NP (DT the) (NN onset))
          (PP (IN of)
            (NP (NNP AA))))
        (PP (IN by)
          (NP
            (NP
              (QP (RB approximately) (CD 2))
              (NNS days))
            (PRN (-LRB- -LRB-)
              (NP (NN day) (CD 10))
              (-RRB- -RRB-)))))
      (, ,)
      (CC and)
      (VP (VBD ameliorated)
        (ADVP
          (NP (DT the) (NN arthritis))
          (RB only))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ late) (NN phase))
            (PRN (-LRB- -LRB-)
              (NP (NN day) (CD 27))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Differential) (JJ clinical) (NNS effects))
      (PP (IN at)
        (NP
          (NP (DT the) (NN onset))
          (PP (IN of)
            (NP (NNP AA))))))
    (VP (VBD were)
      (VP
        (VP (VBN paralleled)
          (PP (IN by)
            (NP
              (NP (DT a) (NN differential) (NN influence))
              (PP (IN of)
                (NP
                  (NP (DT the) (NNS mAbs))
                  (PP (IN on)
                    (NP (JJ T-cell) (NNS functions))))))))
        (, ,)
        (VP (VBN i.e.)
          (PP (IN in)
            (NP (NN comparison)))
          (PP (IN with)
            (NP (NNP OX35)
              (CC and)
              (NNP W3/25)))
          (, ,)
          (NP
            (NP (DT the) (`` `) (JJ accelerating) ('' ') (NN mAb))
            (SBAR
              (S
                (NP (NNP RIB5/2))
                (VP (VBD failed)
                  (S
                    (VP (TO to)
                      (VP (VB increase)
                        (NP
                          (NP (DT the) (JJ delayed-type) (NN hypersentivity))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP DTH))
                            (-RRB- -RRB-)))
                        (PP (TO to)
                          (NP (NNP Mycobacterium) (NNP tuberculosis)))))))))))
        (, ,)
        (VP (VBN increased)
          (NP
            (NP (DT the)
              (ADJP (IN in) (NN vitro))
              (NN tumor) (NNS necrosis) (NN factor))
            (PRN (-LRB- -LRB-)
              (NP (NNP TNF))
              (-RRB- -RRB-))))
        (: -)
        (VP (VBN α)
          (NP (NN secretion)))
        (, ,)
        (CC and)
        (VP
          (ADVP (RBR more) (RB strongly))
          (VBN induced)
          (NP
            (NP (JJ NF-κB) (VBG binding) (NN activity))
            (PP (IN after)
              (NP
                (NP (JJ anti-CD4) (NN preincubation))
                (CC and)
                (NP (JJ subsequent) (NNS TCR/CD3-stimulation))))))))
    (. .)))

(ROOT
  (S
    (PP (VBG Depending)
      (PP (IN on)
        (NP (PRP$ their) (JJ epitope) (NN specificity))))
    (, ,)
    (NP (JJ different) (JJ anti-CD4) (NNS mAbs))
    (ADVP (RB differentially))
    (VP (VBP influence)
      (NP
        (NP (JJ individual) (NN proinflammatory) (NNS functions))
        (PP (IN of)
          (NP (NNP T) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (JJ fine) (NN regulation))
    (VP
      (VP (MD may)
        (VP (VB explain)
          (NP (DT the) (NN differential) (NN efficacy))
          (PP (IN in)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP (NNP AA)))))))
      (CC and)
      (VP (MD may)
        (VP (VB contribute)
          (PP (TO to)
            (NP
              (NP (DT the) (NN understanding))
              (PP (IN of)
                (NP
                  (NP (JJ such) (NNS treatments))
                  (PP (IN in)
                    (NP (JJ other) (NNS immunopathologies))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Introduction) (NNP CD4) (NNP +))
    (VP (VBP T)
      (S
        (NP
          (NP (NNS cells))
          (CC and)
          (NP (PRP$ their) (JJ cytokine) (NNS products)))
        (VP (VB play)
          (NP (DT an) (JJ important) (NN role))
          (PP (IN in)
            (NP
              (NP (JJ rheumatoid) (NN arthritis)
                (CC and)
                (JJ experimental) (NNS models))
              (PP (IN of)
                (NP (NN arthritis)))))))
      (, ,)
      (S
        (ADVP (RB therefore))
        (VP (VBG representing)
          (NP (JJ potential) (JJ therapeutic) (NNS targets))
          (S
            (VP (VBG -LSB-)
              (NP (CD 1) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ specific) (JJ therapeutic) (NN approach))
    (VP (VBZ is)
      (NP
        (NP
          (NP (DT the) (JJ direct) (VBG targeting))
          (PP (IN of)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
          (PP (IN by)
            (NP
              (NP (NN use))
              (PP (IN of)
                (NP (JJ monoclonal) (NNS antibodies)))))
          (PRN (-LRB- -LRB-)
            (VP (VBZ mAbs))
            (-RRB- -RRB-)))
        (PP (IN against)
          (NP (DT the) (NNP CD4) (NN coreceptor)))))
    (. .)))

(ROOT
  (S
    (NP (JJ Anti-CD4) (NNS mAbs)
      (S
        (VP (VB induce)
          (NP
            (NP (DT either) (NN cell) (NN depletion) (JJ -LSB-) (CD 2)
              (ADJP (JJ -RSB-)
                (CC or)
                (JJ functional))
              (NN inactivation))
            (PP (IN of)
              (NP (NNP T) (NNS cells)))))))
    (VP (VBD -LSB-)
      (NP
        (QP (CD 3,4) (CD -RSB-)))
      (, ,)
      (SBAR (IN although)
        (S
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (JJ T-cell) (NNS functions))))
          (VP (VBZ has)
            (ADVP (RB also))
            (VP (VBN been)
              (VP (VBN reported)
                (NP
                  (QP (CD -LSB-) (CD 5))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (JJ contrasting) (NNS effects))
    (VP (MD may)
      (VP (VB explain)
        (NP (DT the) (NN variability))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ clinical) (NN efficacy))
            (PP (IN of)
              (NP (JJ different) (JJ anti-CD4) (NNS mAbs)))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP
                (NP (JJ rheumatoid) (NN arthritis))
                (, ,)
                (NP
                  (NP
                    (ADJP (RB i.e.) (JJ promising))
                    (JJ initial) (NN efficacy))
                  (PP (IN in)
                    (NP (JJ open) (JJ anti-CD4) (NNS trials)))
                  (ADJP (JJ -LSB-)
                    (NP (CD 6,7) (NNS -RSB-)))
                  (, ,)
                  (NP
                    (NP (JJ subsequent) (JJ disappointing) (JJ double-blind) (JJ clinical) (NNS trials))
                    (PRN (-LRB- -LRB-)
                      (VP (VBN reviewed)
                        (PP (IN in)
                          (NP
                            (QP (CD -LSB-) (CD 8))
                            (NNS -RSB-))))
                      (-RRB- -RRB-))))
                (, ,)))))
        (PRN (CC and)
          (, ,)
          (ADVP (RB finally))
          (, ,)
          (NP
            (NP (DT a) (NN revival))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ anti-CD4) (NN treatment) (NN principle))
                (PP (IN with)
                  (NP (JJ new) (, ,) (JJ humanized) (JJ anti-CD4) (NNS mAbs)))))
            (ADJP (JJ -LSB-)
              (NP (CD 9,10) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (DT The) (NN focus))
        (PP (IN of)
          (NP (DT the) (JJ present) (NN study))))
      (VP (VBD was)
        (S
          (VP (TO to)
            (VP (VB analyze)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (DT the) (JJ anti-CD4)))))))))
    (VP (VBZ mAbs)
      (NP (NNP W3/25) (, ,) (NNP OX35) (, ,)
        (CC and)
        (NNP RIB5/2))
      (PP (IN in)
        (NP
          (NP
            (NP (NN rat) (NN adjuvant) (NN arthritis))
            (PRN (-LRB- -LRB-)
              (NP (NNP AA))
              (-RRB- -RRB-)))
          (, ,)
          (NP (DT a) (JJ well-known))
          (, ,))
        (ADVP (RB clearly))))
    (NP (NNP CD4) (NNP +) (NNP T-cell-dependent) (JJ experimental) (NN arthritis) (NN model) (NNP -LSB-) (NNP 11-13) (NNP -RSB-))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS mAbs))
    (VP
      (VP (VBP target)
        (NP
          (NP (JJ different) (NNS epitopes))
          (PP (IN of)
            (NP (DT the) (NNP CD4) (NN molecule)))))
      (CC and)
      (VP (VBP do) (RB not)
        (VP (VB compete)
          (PP (IN for)
            (NP (NNP CD4) (NNP binding) (NNP -LSB-) (CD 14) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (PRP They))
    (VP (VBP are)
      (ADJP (RB equally) (JJ effective)
        (PP (IN in)
          (S
            (VP (VBG suppressing)
              (NP (NNP AA))
              (PP (IN upon)
                (NP
                  (NP (NN treatment))
                  (PP (IN of)
                    (NP
                      (NP (VBN established) (NN disease) (VBG -LSB-) (CD 11,12) (NNS -RSB-))
                      (PRN (-LRB- -LRB-)
                        (CC and)
                        (S
                          (NP (NNS authors))
                          (VP (VBP own)
                            (NP (JJ unpublished) (NNS observations))))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (JJ preventive) (NN treatment))
      (PP (IN with)
        (NP
          (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NN W3/25))
          (, ,)
          (NP (NNP OX35))
          (, ,)
          (CC and)
          (NP (NNP RIB5/2))
          (PRN (-LRB- -LRB-)
            (PP (IN on)
              (NP
                (NP
                  (NP (NNS days))
                  (NP (CD -1) (, ,) (NN 0) (, ,) (CD 3) (, ,)
                    (CC and)
                    (CD 6))
                  (, ,)
                  (ADVP (RB i.e.)
                    (NP (CD 1) (NN day))
                    (PP (IN before)
                      (NP (NNP AA) (NN induction)))))
                (, ,)
                (UCP
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN day))
                      (PP (IN of)
                        (NP (JJ induction) (JJ -LSB-) (NN day) (NNP 0) (NNP -RSB-)))))
                  (, ,)
                  (CC and)
                  (ADVP (RB thereafter)))))
            (-RRB- -RRB-)))))
    (VP (VBD had)
      (NP
        (NP (JJ opposite) (NNS effects))
        (PP (IN in)
          (NP
            (NP (DT the) (NN induction) (NN phase))
            (PP (IN of)
              (NP (NNP AA)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN In) (NN order)
      (S
        (VP (TO to)
          (VP (VB explain)
            (NP (DT this) (NN differential))
            (ADVP (RB efficacy))))))
    (, ,)
    (NP (JJ several) (NNS parameters))
    (VP (VBD were)
      (VP (VBN analyzed)))
    (. .)))

(ROOT
  (S
    (PP
      (ADVP (RB Methods))
      (IN For)
      (NP (NNS animals)))
    (, ,)
    (NP
      (NP (NN arthritis) (NN model))
      (, ,)
      (NP
        (NP (NNS antibodies))
        (, ,)
        (CC and)
        (ADVP (RB affinity))
        (NP
          (NP (NN determination))
          (-LRB- -LRB-)
          (NP (NN surface) (NN plasmon) (NN resonance))
          (-RRB- -RRB-)))
      (, ,))
    (VP (VBP see)
      (NP (NNP Supplementary) (NN material)))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP T-cell) (NNP reactivity))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN in)
            (NP (NN vivo)))
          (PP
            (PP (IN by)
              (NP
                (NP (JJ delayed-type) (NN hypersensitivity))
                (PRN (-LRB- -LRB-)
                  (NP (NNP DTH))
                  (-RRB- -RRB-))))
            (CC and)
            (PP (IN in)
              (NP
                (NP
                  (ADJP (NN vitro)
                    (PP (IN by)
                      (NP (NN proliferation))))
                  (NN assay))
                (CC or)
                (NP (VBN mixed) (JJ lymphocyte) (NN culture))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNS cytokines))
      (VP (VBD were)
        (VP (VBN measured)
          (PP (IN by)
            (NP (NN bioassay)
              (CC or)
              (NN ELISA)))
          (PRN (-LRB- -LRB-)
            (S
              (VP (VB see)
                (S
                  (NP (NNP Supplementary) (NN material))
                  (PRN (: ;)
                    (PP (IN for)
                      (NP
                        (NP (NN tumor) (NN necrosis) (NN factor))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP TNF))
                          (-RRB- -RRB-))))
                    (: -))
                  (VP (VB α)
                    (NP
                      (QP (CD -LSB-) (CD 15))
                      (NNS -RSB-))))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN by)
          (NP
            (NP
              (NP (NN preincubation))
              (PP (IN with)
                (NP (JJ anti-CD4) (NNS mAbs))))
            (CC and)
            (NP
              (NP (JJ subsequent) (NN stimulation))
              (PP (IN of)
                (NP (JJ T-cell) (NNS receptors))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Electrophoretic) (JJ mobility) (NN shift) (NN assay))
      (PRN (-LRB- -LRB-)
        (NP (NNP EMSA))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (ADVP (IN as))
      (VP (VBN described)
        (PP (IN in)
          (NP (DT the) (NNP Supplementary) (NN material)))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (JJ statistical) (NN analysis)))
    (, ,)
    (NP (PRP we))
    (VP (VBD used)
      (SBAR
        (S
          (NP
            (NP (DT the) (NNP Mann))
            (: --)
            (NP
              (NP (NNP Whitney))
              (PRN (-LRB- -LRB-)
                (NP (NNP U))
                (-RRB- -RRB-))
              (NP (NN test/Spearman) (NN rank) (NNP correlation) (-LRB- -LRB-) (NNP P) (NNP ≤) (CD 0.05)))
            (: ;))
          (VP (VBP see)
            (NP (NNP Supplementary) (NN material))))))
    (-RRB- -RRB-) (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Results) (NN Preventive) (NN treatment))
      (PP (IN with)
        (NP
          (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NN W3/25)
            (CC and)
            (NN OX35))
          (VP (VBN led)
            (PP (TO to)
              (NP
                (NP (DT a) (JJ marked) (, ,) (JJ significant) (NN suppression))
                (PP (IN of)
                  (NP (DT the) (NN arthritis)))))))))
    (VP (VBP score)
      (PP (IN from)
        (NP (NN day)))
      (NP
        (NP
          (QP (CD 13) (TO to) (CD 30)))
        (PP (IN in)
          (NP
            (NP (NN comparison))
            (PP (IN with)
              (NP (JJ PBS-treated) (NNS animals))))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NNP P) (NNP ≤) (NNP 0.05))
          (: ;)
          (NP (NNP Fig.) (CD 1)))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (DT the) (JJ anti-CD4) (NN mAb) (NN RIB5/2))
    (VP
      (VP
        (ADVP (RB significantly))
        (VBD accelerated)
        (NP
          (NP (DT the) (NN onset))
          (PP (IN of)
            (NP
              (NP (DT the) (NN arthritis))
              (PP (IN by)
                (NP
                  (NP
                    (QP (RB approximately) (CD 2))
                    (NNS days))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP P) (NNP ≤))
                      (SBAR
                        (S
                          (NP
                            (NP (CD 0.01))
                            (: ;)
                            (NP
                              (NP (NNS days) (CD 11))
                              (, ,)
                              (NP (CD 12)))
                            (: ;))
                          (VP (VBP see)
                            (NP (NNP Fig.) (CD 1))))))
                    (-RRB- -RRB-)))))))
        (, ,)
        (S
          (VP (VBG resulting)
            (PP (IN in)
              (NP
                (NP (DT an) (JJ aggravated) (JJ clinical) (NN score))
                (PP (IN on)
                  (NP (DT these) (NNS days))))))))
      (, ,)
      (CC and)
      (VP (VBD ameliorated)
        (NP (JJ clinical) (NNS signs))
        (ADVP (RB only))
        (PP (IN from)
          (NP
            (NP (NN day) (CD 27))
            (PRN (-LRB- -LRB-)
              (S
                (NP (NNP P))
                (VP (VBZ ≤)
                  (NP
                    (NP (CD 0.05))
                    (: ;)
                    (VP (VB see)
                      (NP (NNP Fig.) (CD 1))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (VBG accelerating) (NN effect))
        (PP (IN of)
          (NP (DT the) (NN mAb) (NN RIB5/2))))
      (VP (VBD was)
        (VP (VBN reproduced)
          (PP (IN in)
            (NP (CD two) (JJ additional) (NN treatment) (NNS experiments))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this) (NN effect))
      (VP (VBD was)
        (VP (VBN observed)
          (PP (IN despite)
            (NP
              (NP (DT a) (JJ variable) (NN onset))
              (PP (IN of)
                (NP (NNP AA)))))
          (PP (IN in)
            (NP
              (NP (DT the) (JJ PBS-treated) (NNS animals))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN day) (CD 9))
                  (PP (TO to)
                    (NP (CD 11))))
                (-RRB- -RRB-))
              (: ;)
              (ADJP (JJ i.e.)
                (PP (IN in)
                  (NP
                    (NP (DT all) (NNS experiments))
                    (, ,)
                    (NP
                      (NP (DT the) (NN onset))
                      (PP (IN of)
                        (NP
                          (NP (NNP AA))
                          (VP (VBN occurred)
                            (PP
                              (ADVP
                                (NP (CD 2) (NNS days))
                                (RBR earlier))
                              (IN than) (IN in)
                              (NP (DT the) (NNS controls)))))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN In) (NN order)
      (S
        (VP (TO to)
          (VP (VB identify)
            (NP (JJ potential) (NNS mechanisms))
            (PP (IN for)
              (NP (DT these) (NN differential) (NNS effects)))))))
    (, ,)
    (NP
      (NP
        (NP (DT the) (JJ molecular) (NNS properties))
        (PP (IN of)
          (NP (DT the) (NNS mAbs))))
      (CC and)
      (NP
        (NP (PRP$ their) (NN influence))
        (PP
          (PP (IN on)
            (NP
              (NP (JJ T-cell) (NN effector) (NNS functions))
              (PP (IN in)
                (NP (NN vivo)))))
          (CC and)
          (PP (IN in)
            (NP (NNP vitro))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (DT the) (NN sake))
        (PP (IN of)
          (NP (NN simplicity)))))
    (, ,)
    (NP (PRP we))
    (VP (VBP refer)
      (PP (TO to)
        (NP
          (NP
            (NP (DT the) (NN mAb) (NN RIB5/2))
            (PP (IN as)
              (NP (`` `) (JJ accelerating) ('' '))))
          (PRN (-LRB- -LRB-)
            (SBAR (IN although)
              (S
                (NP (DT this) (NN term))
                (VP (VBZ is)
                  (ADJP (JJ applicable)
                    (PP (RB only) (TO to)
                      (NP
                        (NP (DT the) (NN onset))
                        (PP (IN of)
                          (NP (NNP AA)))))))))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (DT the) (JJ mAbs) (NNP W3/25)
              (CC and)
              (NNP OX35))
            (PP (IN as) (`` `)
              (S
                (VP (VBG ameliorating)))
              ('' '))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Calculation))
      (PP (IN of)
        (NP
          (NP (DT the)
            (ADJP (RB affinity) (JJ constant)))
          (PRN (-LRB- -LRB-)
            (NP (NNP KA))
            (-RRB- -RRB-)))))
    (VP (VBD resulted)
      (PP (IN in)
        (NP (JJ comparable) (NNS values)))
      (PP (IN for)
        (NP (NNP OX35)
          (CC and)
          (NNP RIB5/2)))
      (PRN (-LRB- -LRB-)
        (S
          (VP (VB see)
            (NP (NNP Supplementary) (NNP Table) (CD 1))))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (NN affinity))
      (PP (IN of)
        (NP (NNP W3/25))))
    (VP (VBD was)
      (ADJP (JJ 50-fold)
        (SBAR (IN that)
          (FRAG
            (PP (IN for)
              (NP (DT the) (CD two) (JJ other) (NNS mAbs)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP
            (NP (DT the) (NN association) (NN rate) (NN constants))
            (PRN (-LRB- -LRB-)
              (NP (NNS kass))
              (-RRB- -RRB-)))
          (PP (IN for)
            (NP (DT all) (CD three) (NNS mAbs))))
        (VP (VBD were)
          (PP (IN within)
            (NP
              (NP (DT the) (JJ same) (NN order))
              (PP (IN of)
                (NP (NN magnitude))))))))
    (, ,)
    (NP
      (NP (JJ striking) (NNS differences))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (IN up) (TO to) (CD 40-fold)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN observed)
        (PP (IN for)
          (NP
            (NP (DT the) (JJ dissociation) (NN rate) (NNS constants))
            (PRN (-LRB- -LRB-)
              (NP (NNS kdiss))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (SBAR (IN although)
      (S
        (NP
          (NP (NNS differences))
          (PP (IN in)
            (NP (JJ overall) (NN affinity))))
        (VP (VBD did) (RB not)
          (VP (VB match)
            (NP (NN differential))
            (NP (JJ clinical) (NN efficacy))))))
    (, ,)
    (NP (DT the) (VBG accelerating) (NN mAb) (NN RIB5/2))
    (VP (VBD displayed)
      (NP (DT the) (JJS highest) (NNS kdiss)))
    (. .)))

(ROOT
  (S
    (NP (NNP T-cell) (NNP reactivity))
    (VP (VBD was)
      (VP (VBN investigated)
        (PP (IN on)
          (NP
            (NP (NN day) (CD 13))
            (PP (IN of)
              (NP (NNP AA) (, ,) (NNP i.e.)))))
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP
              (NP (DT the) (JJ clinical) (NNS differences))
              (PP (IN between)
                (NP
                  (NP (DT the) (VBG accelerating))
                  (CC and)
                  (NP (VBG ameliorating) (JJ anti-CD4) (NNS mAbs)))))
            (VP (VBD were)
              (ADJP (JJ maximal)))))))
    (. .)))

(ROOT
  (S
    (PP (VBN Compared)
      (PP (TO to)
        (NP (DT the) (JJ PBS-treated) (NN control) (NN group))))
    (, ,)
    (NP (DT the) (NN ameliorating))
    (VP (VBP mAb)
      (NP
        (NP (NNP OX35))
        (VP (VBN induced)
          (NP
            (NP (DT a) (JJ significant) (NN increase))
            (PP (IN of)
              (NP (DT the) (NNP DTH))))
          (PP (IN in)
            (NP (NN response)))
          (PP (TO to)
            (NP
              (NP (DT the) (JJ arthritogen) (NNP Mycobacterium) (NNP tuberculosis))
              (PRN (-LRB- -LRB-)
                (NP (NNP Supplementary)
                  (QP (CD Fig.) (CD 1)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ other) (VBG ameliorating) (JJ anti-CD4) (NN mAb))
        (, ,)
        (NP (NNP W3/25))
        (, ,))
      (ADVP (RB also))
      (VP (VBN induced)
        (NP (DT an) (NN increase))))
    (, ,)
    (CC but)
    (S
      (NP (JJ statistical) (NN significance))
      (VP (VBD was) (RB not)
        (VP (VBN reached))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP
          (NP (DT the) (JJ accelerating) (JJ anti-CD4) (NN mAb))
          (, ,)
          (NP (NNP RIB5/2))
          (, ,))))
    (VP (VBD had)
      (NP
        (NP (RB virtually) (DT no) (NN influence))
        (PP (IN on)
          (NP (DT the) (NNP DTH)))))
    (. .)))

(ROOT
  (S
    (PP (IN Upon)
      (NP
        (NP (NN stimulation))
        (PP (IN with)
          (NP
            (NP (NN concanavalin) (NN A))
            (PRN (-LRB- -LRB-)
              (NP (NNP ConA))
              (-RRB- -RRB-))))))
    (, ,)
    (NP
      (NP (JJ total) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (NN RIB5/2-treated) (NNS animals))))
    (VP (VBD showed)
      (NP (JJR lower) (NN proliferation) (NNS rates))
      (PP (IN than)
        (NP (DT those)))
      (PP (IN from)
        (NP
          (NP
            (ADJP (JJ W3/25) (: -)
              (CC or)
              (JJ OX35-treated))
            (NNS rats))
          (PRN (-LRB- -LRB-)
            (NP (NNP Supplementary)
              (QP (CD Fig.) (CD 2)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (S
      (PP (IN In)
        (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture)))
      (, ,)
      (NP (NNP RIB5/2))
      (VP (VBD was)
        (ADVP (RB also))
        (NP
          (NP (DT the)
            (ADJP (RBS most) (JJ potent))
            (NN inhibitor))
          (PP (IN of)
            (NP
              (NP (JJ T-cell) (NN activation))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN case))
                  (PP (IN of)
                    (NP (JJ total) (NNP T) (NNS cells))))))))))
    (: ;)
    (S
      (ADVP (RB however))
      (, ,)
      (NP (DT this))
      (VP (VBD was) (RB not)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP
                (QP (CD purified) (CD CD4))
                (NNP +) (NNP T) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NNP Supplementary)
                  (QP (CD Fig.) (CD 4)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB simulate)
          (NP
            (NP (DT the) (JJ preventive) (JJ therapeutic) (NN application))
            (PP (IN in)
              (NP (NNP AA))))
          (, ,)
          (S
            (VP (VBG i.e.)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP (JJ anti-CD4) (NNS mAbs))))))))))
    (, ,)
    (NP (JJ purified) (NN spleen) (CD CD4) (NNP +) (NNP T) (NNS cells))
    (VP
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP (JJ anti-CD4) (NN mAb)))))
      (CC and)
      (PRN (, ,)
        (PP (IN after)
          (NP (NN cross-linking)))
        (, ,))
      (VP (VBN stimulated)
        (PP (IN with)
          (NP
            (NP (JJ plate-bound) (JJ anti-T-cell-receptor)
              (PRN (-LRB- -LRB-)
                (NP (NNP TCR))
                (-RRB- -RRB-))
              (NN α) (JJ /) (NN β) (NNS mAb))
            (PRN (-LRB- -LRB-)
              (VP
                (ADVP (RB so))
                (VBN called)
                (NP (JJ anti-CD4) (NN preincubation)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (JJ anti-CD4) (NN preincubation))
      (PP (IN with)
        (NP (DT the) (VBG accelerating) (JJ anti-CD4) (NN mAb) (NN RIB5/2))))
    (VP (VBD led)
      (PP (TO to)
        (NP (DT a)
          (ADJP (RB significantly) (JJR higher))
          (NN TNF-α) (NN secretion)))
      (, ,)
      (PP (IN in)
        (NP (NN comparison)))
      (PP (DT both)
        (PP (IN with)
          (NP (DT the) (JJ isotype) (NN control)))
        (CC and)
        (PP (IN with)
          (NP
            (NP (DT the) (CD two) (JJ other) (JJ anti-CD4) (NNS mAbs))
            (, ,)
            (NP
              (NP (NNP W3/25)
                (CC and)
                (NNP OX35))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD Fig.) (CD 2)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Differential) (NN induction))
      (PP (IN of)
        (NP
          (NP (NNP TNF-α))
          (PP (IN by)
            (NP (NNP RIB5/2))))))
    (VP (VBD was)
      (ADVP (RB also))
      (VP (VBN seen)
        (PP
          (PP (IN after)
            (NP
              (ADJP (JJ CD4-cross-linking)
                (PP (IN on)
                  (NP (DT the) (NNP CD4) (NNP +) (NNP T-cell))))
              (NN clone) (NNS A2b)))
          (CC or)
          (PP (IN on)
            (NP
              (NP (NNP TCR-stimulated) (NNP CD4) (NNP +) (NNP T-cell) (NNP blasts))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (DT both) (NNS data))
                  (VP (VBZ sets) (RB not)
                    (VP (VBN shown))))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NNP IFN-γ) (, ,) (NNP IL-10) (, ,)
        (CC and)
        (NNP IL-4)))
    (, ,)
    (VP (VB see)
      (NP (NNP Supplementary) (NN material)))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))
        (VP (VBP recognize)
          (NP
            (NP (JJ distinct) (NNS epitopes))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ CD4) (NN molecule))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ is)
                      (VP (VBN involved)
                        (PP (IN in)
                          (S
                            (VP (VBG signaling)
                              (NP (NNS cascades)))))))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN influence))
      (PP (IN of)
        (NP
          (NP (DT these) (NNS mAbs))
          (PP (IN on)
            (NP (JJ early) (JJ signaling) (NNS events))))))
    (VP (VBD was)
      (VP
        (ADVP (RB also))
        (VBN investigated)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT No) (NN influence))
      (PP (IN at)
        (NP
          (NP (DT all))
          (PP (IN of)
            (NP (DT the) (JJ anti-CD4) (NNS mAbs))))))
    (VP (VBD was)
      (VP (VBN found)
        (PP (IN for)
          (NP
            (NP
              (NP
                (NP (NN calcium) (NN influx))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ primary) (NN CD4) (NNS +))
                    (VP (VBN spleen)
                      (NP (NNP T) (NNS cells))))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (NN phosphorylation))
                (PP (IN of)
                  (NP (JJ src-homology-domain-containing) (NN protein)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Shc))
                  (-RRB- -RRB-)))
              (, ,)
              (CC or)
              (NP
                (NP (DT the) (NN translocation))
                (PP (IN of)
                  (NP
                    (NP (JJ nuclear) (NN factor))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (VBN activated) (NN T) (NNS cells))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP NF-AT))
                            (-RRB- -RRB-)))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (DT both) (JJ primary) (NNP CD4) (NNP +) (NNP T) (NNS cells))
                            (CC and)
                            (NP (JJ clone) (NNS A2b)))
                          (-RRB- -RRB-))))))))
            (, ,)
            (CC and)
            (NP
              (NP (DT the) (NN activity))
              (PP (IN of)
                (NP
                  (NP (NNS p59fyn))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP A2b))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN activity))
      (PP (IN of)
        (NP
          (NP (DT the)
            (ADJP (JJ CD4-associated)
              (NP (CD p56lck))
              (PP (IN after)
                (NP (NNP CD4))))
            (NN cross-linking))
          (PRN (-LRB- -LRB-)
            (NP (NNP A2b))
            (-RRB- -RRB-)))))
    (VP (VBD was)
      (ADJP (RB comparably) (JJ increased)
        (PP (IN by)
          (NP
            (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (PDT all) (DT the) (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (VBG binding) (NNS activities))
      (PP (IN of)
        (NP
          (NP
            (NP (DT the) (NN transcription) (NNS factors) (NN activator) (NN protein-1))
            (PRN (-LRB- -LRB-)
              (NP (NNP AP-1))
              (-RRB- -RRB-)))
          (CC and)
          (NP (NNP NF-κB)))))
    (VP (VBD were)
      (VP (VBN determined)
        (PP (IN in)
          (NP
            (NP (JJ nuclear) (NNS extracts))
            (PP (IN of)
              (NP (JJ spleen) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
            (VP (VBN preincubated)
              (PP (IN with)
                (NP (JJ anti-CD4) (NNS mAbs))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN activity))
      (PP (IN of)
        (NP (NN AP-1))))
    (VP (VBD was)
      (ADVP (RB slightly)
        (CC but)
        (RB significantly))
      (VP (VBN decreased)
        (PP (IN by)
          (NP (NN pretreatment)))
        (PP (IN with)
          (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs)))
        (, ,)
        (PP (TO to)
          (NP
            (NP (DT a) (JJ similar) (NN degree))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD Fig.) (CD 3)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (NN preincubation))
      (PP (IN with)
        (NP
          (NP (DT the) (VBG accelerating) (JJ anti-CD4) (NN mAb))
          (, ,)
          (NP (NNP RIB5/2))
          (, ,)
          (VP (VBN induced)
            (NP
              (NP (DT a)
                (ADJP (RB significantly) (JJR higher))
                (JJ binding) (NN activity))
              (PP (IN of)
                (NP (NNP NF-κB))))
            (PP (IN than))))))
    (VP (VBD did)
      (NP (NN preincubation))
      (PP (IN with)
        (NP
          (NP (DT the) (JJ ameliorating) (NNP W3/25)
            (CC and)
            (NNP OX35))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (ADVP (RB only) (RB moderately))
              (VP (VBD increased)
                (NP
                  (NP (DT the) (JJ NF-κB) (VBG binding) (NN activity))
                  (PRN (-LRB- -LRB-)
                    (S
                      (VP (VB see)
                        (NP (NNP Fig.) (CD 3))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Discussion))
      (NP (DT The) (JJ present) (NN study)))
    (VP (VBZ shows)
      (NP
        (NP (NN differential) (JJ clinical) (NN efficacy))
        (PP (IN of)
          (NP
            (NP (CD three) (JJ anti-CD4) (NNS mAbs))
            (PP (IN in)
              (NP
                (NP (DT the) (JJ preventive) (NN treatment))
                (PP (IN of)
                  (NP (NNP AA)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN lack))
      (PP (IN of)
        (NP
          (NP (NN differential) (JJ clinical) (NN efficacy))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ same) (NNS mAbs))
              (PP (IN in)
                (NP (JJ established) (NNP AA))))))))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN explained)
          (PP (IN by)
            (NP
              (NP (DT a)
                (ADJP (RB completely) (JJ divergent))
                (JJ immunological) (NN constellation))
              (PP (IN in)
                (NP (NN connection)))))
          (PP (IN with)
            (NP
              (NP (DT the) (VBN known) (NN differential) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (JJ anti-CD4) (NNS mAbs))
                  (PP (IN on)
                    (NP
                      (ADJP (JJ naive)
                        (CC and)
                        (JJ memory))
                      (NN T) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (JJ successful) (NN treatment))
          (PP (IN with)
            (NP (JJ anti-CD4) (NNS mAbs))))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN achieved)
              (PP (IN in)
                (NP (JJ various) (NN arthritis) (NNS models)))
              (S
                (VP (VBG -LSB-)
                  (NP (CD 12,16-18) (NNS -RSB-)))))))))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (NP
        (NP (DT no) (NN evidence))
        (PP (IN for)
          (NP
            (NP (DT a) (NN differential) (NN efficacy))
            (PP (IN of)
              (NP
                (NP (JJ anti-CD4) (NNS mAbs))
                (PP (IN in)
                  (NP
                    (NP (NN arthritis) (NNS models))
                    (PP (TO to)
                      (NP (NN date)))))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (DT this) (NN finding))
      (VP (MD may)
        (VP (VB represent)
          (NP
            (NP (DT the) (JJ experimental) (NN counterpart))
            (PP (IN of)
              (NP (DT the) (VBG conflicting) (NNS results)))))))
    (VP (VBD observed)
      (ADVP (RB thus) (RB far))
      (PP (IN in)
        (NP
          (NP (NNS studies))
          (PP (IN of)
            (NP (JJ human) (JJ rheumatoid) (NN arthritis) (NNS -LSB-))))))
    (NP (CD 6,8,10) (NN -RSB-))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (S
        (NP
          (NP (NN contrast))
          (PP (TO to)
            (NP
              (NP (DT a) (JJ reported) (NN study))
              (PP (IN of)
                (NP (JJ experimental) (JJ allergic) (NNS encephalomyelitis))))))
        (VP (VBG -LSB-)
          (NP (CD 19) (NNS -RSB-)))))
    (, ,)
    (NP (DT the) (JJ present) (NN study))
    (VP (VBD did) (RB not)
      (VP (VB confirm)
        (NP
          (NP (DT a) (NN role))
          (PP (IN for)
            (NP (DT the) (NN mAb) (NN isotype))))
        (PP (IN in)
          (NP (NNP AA)))
        (, ,)
        (SBAR (IN as)
          (S
            (NP
              (NP (DT the) (NNS isotypes))
              (PP (IN of)
                (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))))
            (VP (VBD did) (RB not)
              (VP (VB match)
                (NP (PRP$ their) (NN differential) (NN preventive) (NNS effects))
                (PP (IN in)
                  (NP (NNP AA)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG ameliorating) (NN mAb) (NN W3/25))
    (VP (VBD had)
      (NP (DT a)
        (ADJP (RB very) (JJ high))
        (NN affinity))
      (, ,)
      (SBAR (IN as)
        (S
          (ADVP (RB previously))
          (VP (VBD reported)
            (NP
              (QP (CD -LSB-) (CD 20))
              (NNS -RSB-)))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (NP (DT the) (NN affinity))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ other) (NN ameliorating) (NN mAb))
                (, ,)
                (NP (NNP OX35))
                (, ,))))
          (VP (VBD was)
            (ADJP (JJ comparable)
              (PP (TO to)
                (NP
                  (NP (DT that))
                  (PP (IN of)
                    (NP (DT the) (VBG accelerating) (NN mAb)))))))))
      (, ,)
      (ADVP (RB RIB5/2)))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP
      (NP (DT a) (NN contribution))
      (PP (IN of)
        (NP
          (NP (DT the)
            (ADJP (RB strikingly) (JJR higher))
            (NNS kdiss))
          (PP (IN of)
            (NP
              (NP (DT the) (NN mAb) (NN RIB5/2))
              (PP (TO to)
                (NP (PRP$ its) (JJ differential) (JJ clinical) (NNS effects))))))))
    (VP (MD can) (RB not)
      (VP (VB be)
        (VP (VBN excluded) (, ,)
          (PP (IN in)
            (NP
              (NP (NN analogy))
              (PP (TO to)
                (NP
                  (NP
                    (ADJP (JJ high)
                      (CC and)
                      (JJ low))
                    (NNS kdiss))
                  (PP (IN for)
                    (NP (JJ agonistic)
                      (CC and)
                      (JJ antagonistic) (NNS TCR-peptides)))))))
          (, ,)
          (S
            (VP
              (ADVP (RB respectively))
              (VBG -LSB-)
              (NP (CD 21) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN spite))
        (PP (IN of)
          (NP (DT these) (NNS considerations)))))
    (, ,)
    (NP
      (NP (NN recognition))
      (PP (IN of)
        (NP
          (NP (JJ different) (NNS epitopes))
          (PP (IN by)
            (NP (DT the) (NNS mAbs))))))
    (VP (VBD -LSB-)
      (SBAR
        (S
          (NP
            (NP (CD 14) (NNS -RSB-))
            (, ,)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (JJ distinct) (JJ functional))
                  (NNS consequences))
                (PP (IN for)
                  (NP (DT the) (NN target) (NNS cells)))))
            (, ,))
          (VP (VBZ remains)
            (NP
              (NP (DT the)
                (ADJP (RBS most) (JJ likely))
                (NN explanation))
              (PP (IN for)
                (NP (PRP$ their) (NN differential) (JJ clinical) (NN efficacy) (NNP -LSB-) (CD 22) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (VBG binding) (NNS sites))
          (PP (IN of)
            (NP (NNP W3/25)
              (CC and)
              (NNP OX35))))
        (VP (VBP are)
          (VP (VBN situated)
            (PP (IN in)
              (NP
                (NP (DT the)
                  (NP (NNP C) (NNP ´)
                    (PRN (: --)
                      (NP
                        (NP
                          (QP ($ C) (CD ´) (CD ´))
                          (NN region))
                        (PP (IN of)
                          (NP
                            (NP (NN domain) (NN D1))
                            (CC and)
                            (NP (DT the) (NN B)))))
                      (: --))
                    (NNP C))
                  (NN region))
                (PP (IN of)
                  (NP
                    (NP (NN domain) (NN D2))
                    (PP (IN of)
                      (NP (DT the) (NNP CD4) (NN molecule)))))))
            (, ,)
            (S
              (ADVP (RB respectively))
              (VP (VBG -LSB-)
                (NP (CD 23) (NNS -RSB-))))))))
    (, ,)
    (NP (PRP we))
    (VP (MD could)
      (ADVP (RB roughly))
      (VP (VB localize)
        (NP
          (NP (DT the) (NN epitope))
          (PP (IN of)
            (NP (NNP RIB5/2))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN F))
            (: --)
            (NP
              (NP (NNP G) (NN region))
              (PP (IN of)
                (NP (NN domain) (NN D1))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP
              (VP (VBN demonstrated)
                (PP (IN by)
                  (NP
                    (NP (JJ effective) (NN competition))
                    (PP (IN with)
                      (NP (DT the) (NN mAb) (NN OX65)))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNS data))
                        (VP (RB not) (VBN shown)))
                      (-RRB- -RRB-)))))
              (, ,)
              (VP (VBN known)
                (S
                  (VP (TO to)
                    (VP (VB bind)
                      (NP
                        (NP (DT this) (NN region))
                        (PP (IN of)
                          (NP (DT the) (NNP CD4) (NN molecule))))))))
              (S
                (VP (VBG -LSB-)
                  (NP (CD 23) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Binding))
      (PP (IN of)
        (NP
          (NP (JJ anti-CD4) (NNS mAbs))
          (PP (TO to)
            (NP
              (NP (JJ separate) (NNS epitopes))
              (PP (IN of)
                (NP (DT the) (NNP CD4) (NN molecule))))))))
    (VP (MD could)
      (VP (VB result)
        (PP (IN in)
          (NP
            (NP (NN differential) (NNS effects))
            (PP (IN on)
              (NP (JJ T-cell) (NNS functions)))))
        (PP (IN by)
          (S
            (VP
              (VP (VBG inducing)
                (NP
                  (NP
                    (NP (JJ distinct) (JJ conformational) (NNS changes))
                    (PP (IN of)
                      (NP (DT the) (NN extracellular))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN intracellular) (NNS parts))
                    (PP (IN of)
                      (NP (DT the) (NN CD4))))))
              (, ,)
              (VP (VBG resulting)
                (PP (IN in)
                  (NP
                    (NP (VBN modified) (NN interaction))
                    (PP (IN with)
                      (NP (JJ other) (JJ signaling) (NNS molecules)))))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBZ has)
              (VP (VBN been)
                (VP (VBN discussed)
                  (ADVP (RB recently))
                  (PP (IN with)
                    (NP (NN regard)))
                  (PP (TO to)
                    (NP
                      (NP (DT the) (JJ aspartate) (NN receptor))
                      (VP (VBG -LSB-)
                        (NP (CD 24) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (DT the) (JJ ameliorating) (JJ anti-CD4) (NNS mAbs) (NN W3/25)
      (CC and)
      (NN OX35)
      (PRN (-LRB- -LRB-)
        (CONJP (CC but)
          (RB not))
        (NP
          (NP (DT the) (JJ accelerating) (NN mAb))
          (, ,)
          (NP (NNP RIB5/2)))
        (-RRB- -RRB-))
      (NN numerically/significantly))
    (VP (VBD increased)
      (NP (DT the) (NNP DTH))
      (PP (TO to)
        (NP (DT the) (JJ arthritogen) (NNP M.) (NNP tuberculosis))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ total) (JJ T-cell) (NN population)))
    (, ,)
    (NP
      (NP (CD two))
      (PP (IN of)
        (NP
          (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))
          (PRN (-LRB- -LRB-)
            (NP (CC and)
              (PP (IN in)
                (NP (NNP purified) (NNP CD4) (NNP +) (NNP T)))
              (NP
                (NP (NNS cells))
                (, ,)
                (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))))
            (-RRB- -RRB-)))))
    (VP (VBD increased)
      (NP (DT the)
        (ADJP (IN in) (NN vitro))
        (NN reactivity))
      (PP (TO to)
        (NP (NNP ConA))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN case))
        (PP (IN of)
          (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
    (, ,)
    (NP (DT this) (VBN increased) (NN reactivity))
    (VP (VBD was)
      (ADVP (RB negatively))
      (VP (VBN correlated)
        (PP (IN with)
          (NP
            (NP (DT the) (JJ clinical) (NN score))
            (PP (IN of)
              (NP (JJ individual) (NNS animals)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ successful) (NN mode))
      (PP (IN of)
        (NP
          (NP (NN action))
          (PP (IN of)
            (NP
              (NP (JJ anti-CD4) (NNS mAbs))
              (PP (IN in)
                (NP
                  (NP
                    (NP (NNS arthritides))
                    (SBAR
                      (S
                        (VP (MD may)
                          (ADVP (RB therefore))
                          (VP (VB be)
                            (VP (VBN based)
                              (PP (IN on)
                                (S
                                  (VP (VBG increasing)
                                    (NP
                                      (NP (DT the) (NN reactivity))
                                      (PP (IN of)
                                        (NP
                                          (NP (DT a) (NN subpopulation))
                                          (PP (IN of)
                                            (NP (JJ regulatory) (NNP T) (NNS cells))))))))))))))
                    (, ,)
                    (NP
                      (NP (DT an) (NN interpretation))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (VBZ is)
                            (VP (VBN supported)
                              (PP (IN by)
                                (NP (FW i))))))))
                    (-RRB- -RRB-))
                  (SBAR
                    (S
                      (NP
                        (NP (DT the) (NN increase))
                        (PP (IN of)
                          (NP
                            (NP (NNP T-cell) (NNP reactivity))
                            (PP (IN in)
                              (NP
                                (NP (DT some) (NNS patients))
                                (VP
                                  (ADVP (RB successfully))
                                  (VBN treated)
                                  (PP (IN with)
                                    (NP (JJ anti-CD4) (NNS mAbs)))))))))
                      (VP (VBZ -LSB-)
                        (PRN
                          (NP
                            (NP (CD 6) (NNS -RSB-))
                            (, ,)
                            (NP (NN ii)))
                          (-RRB- -RRB-))
                        (NP
                          (NP (DT an) (VBN increased) (NN DTH))
                          (PP (TO to)
                            (NP
                              (NP (NNS antigens))
                              (PP (IN like)
                                (NP (NN tetanus))))))))))))))))
    (VP (VBD toxoid)
      (PP (IN in)
        (NP
          (ADJP
            (ADJP (RBR less) (JJ active))
            (PRN
              (NP
                (PP (IN versus)
                  (NP (JJ active) (JJ rheumatoid) (NN arthritis) (NNS -LSB-)))
                (NP
                  (NP (CD 25) (NNS -RSB-))
                  (, ,)
                  (NP (NN iii))))
              (-RRB- -RRB-)))
          (NP
            (NP (DT the) (VBN reduced) (NNS responsiveness))
            (PP (TO to)
              (NP (JJ poly-specific) (NN stimulation)))
            (PP (IN of)
              (NP
                (NP (NN spleen) (NNS cells))
                (PP (IN from)
                  (NP
                    (NP (NNS rats))
                    (PP (IN with)
                      (NP (JJ acute) (NNP AA)))))))
            (PP (IN in)
              (NP (NN comparison))))))
      (PP (IN with)
        (NP
          (NP
            (NP (JJ healthy) (NNS animals))
            (NP
              (QP (CD -LSB-) (CD 26))
              (NNS -RSB-)))
          (, ,)
          (CC and)
          (NP (NN iv))
          (-RRB- -RRB-)))
      (NP
        (NP (DT the)
          (ADJP (RB almost) (JJ complete))
          (NN restoration))
        (PP (IN of)
          (NP (JJ T-cell) (NNS responsiveness))))
      (PP (IN upon)
        (NP (NN disease) (NN resolution/transition)))
      (PP (IN into)
        (NP
          (NP (DT the) (JJ chronic) (NN phase))
          (VP (VBG -LSB-)
            (NP (CD 27) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2))
    (ADVP (RB significantly))
    (VP (VBD increased)
      (NP
        (NP (DT the) (NN secretion))
        (PP (IN of)
          (NP (NNP TNF-α))))
      (, ,)
      (PP (IN as)
        (NP
          (NP
            (ADJP (JJ observed)
              (PP (IN in)
                (NP (JJ primary) (NNP CD4) (NNP +) (NNP T))))
            (NNS cells))
          (PP (DT both)
            (PP (IN upon)
              (NP (JJ anti-CD4) (NN preincubation)))
            (CC and)
            (PP (IN upon)
              (S
                (NP (NNP CD4))
                (VP (VBG cross-linking)
                  (PP (IN after)
                    (NP (NN stimulation)))
                  (PP (IN with)
                    (NP (NNP TCR)))
                  (PRN (-LRB- -LRB-)
                    (S
                      (VP (VB see)
                        (NP (NNP Fig.) (CD 2))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN view))
        (PP (IN of)
          (NP (DT the)
            (ADJP (VBN known)
              (NP
                (NP (JJ local)
                  (CC and)
                  (JJ systemic) (NN importance))
                (PP (IN of)
                  (NP
                    (NP (NNP TNF-α))
                    (PP (IN in)
                      (NP
                        (NP (JJ experimental) (NNP AA) (NNP -LSB-) (NNP 28-30) (NNP -RSB-))
                        (CC and)
                        (NP (JJ human) (JJ rheumatoid) (NN arthritis) (NNS -LSB-))))))))
            (QP (CD 31) (CD -RSB-))))))
    (, ,)
    (NP (DT this) (NN effect))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (NN acceleration))
            (PP (IN of)
              (NP
                (NP (DT the) (NN onset))
                (PP (IN of)
                  (NP (NNP AA)))))))
        (PP (IN after)
          (NP
            (NP (NN pretreatment))
            (PP (IN with)
              (NP (DT the) (NN mAb) (NN RIB5/2)))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ important)
          (PP (IN for)
            (NP
              (NP (DT the) (NN understanding))
              (PP (IN of)
                (NP
                  (NP (NNS pathogenesis))
                  (PP (IN in)
                    (NP (NN arthritis))))))))
        (PP (IN despite)
          (NP
            (NP (JJ predominant) (NN production))
            (PP (IN of)
              (S
                (VP (VBG TNF-α)
                  (PP (IN by)
                    (NP
                      (NP (NNS macrophages/monocytes))
                      (PRN (-LRB- -LRB-)
                        (VP (VBN reviewed)
                          (PP (IN in)
                            (NP
                              (QP (CD -LSB-) (CD 32))
                              (NNS -RSB-))))
                        (-RRB- -RRB-))))
                  (, ,)
                  (SBAR (IN since)
                    (S
                      (NP
                        (NP (JJ TNF-α) (NN production))
                        (PP (IN by)
                          (NP (NNP T) (NNS cells))))
                      (VP (VBZ has)
                        (VP (VBN been)
                          (VP (VBN demonstrated)
                            (PP (DT both)
                              (PP (IN in)
                                (NP (DT the) (JJ synovial) (NNP membrane) (NNP -LSB-) (CD 33) (NNS -RSB-)))
                              (CC and)
                              (PP (IN in)
                                (NP
                                  (NP (JJ lymphoid) (NNS organs))
                                  (PRN (-LRB- -LRB-)
                                    (NP
                                      (NP (NNS authors))
                                      (NP (JJ own) (JJ unpublished) (NNS observations)))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP (JJ TNF-α) (NN production))
        (VP (VBZ is)
          (VP (VBN known)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN regulated)
                    (ADVP (RB predominantly))
                    (PP (IN by)
                      (NP (NNP NF-κB) (NNP -LSB-) (CD 34) (NNS -RSB-)))))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBG revealing)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (VBG accelerating) (NN mAb))
              (, ,)
              (NP
                (NP (NNP RIB5/2))
                (, ,)
                (PP (IN besides)
                  (S
                    (VP (VBG inducing)
                      (NP (JJ TNF-α) (NN secretion))))))
              (, ,))
            (ADVP (RB also))
            (VP
              (ADVP (RB strongly))
              (VBD upregulated)
              (NP
                (ADJP (RB NF-κB) (JJ binding))
                (NN activity)))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBD was)
      (ADJP (RB especially) (JJ striking))
      (SBAR (IN because)
        (S
          (NP
            (NP (VBG binding))
            (PP (IN of)
              (NP
                (NP (DT another) (JJ major) (NN transcription) (NN factor))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (JJ T-cell) (NN activation))
                      (, ,)
                      (NP (NNP AP-1) (NNP -LSB-) (CD 35) (NNP -RSB-))
                      (, ,)))))))
          (VP (VBD was)
            (ADJP (RB even) (RB slightly) (JJ downregulated))
            (PP (IN by)
              (NP (DT the) (JJ anti-CD4) (NNS mAbs)))
            (, ,)
            (PP (IN in)
              (NP
                (NP (NN line))
                (PP (IN with)
                  (NP
                    (NP
                      (ADJP (RB recently) (VBN published))
                      (NNS data))
                    (PP (IN in)
                      (NP (JJ murine) (NNS cells)))
                    (ADJP (JJ -LSB-)
                      (NP (CD 36) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT These) (NNS findings))
      (PP (IN in)
        (NP (PRP$ our) (NN study) (NN support))))
    (, ,)
    (ADVP (RB again))
    (, ,)
    (NP
      (NP (DT the) (NN notion))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP
            (NP
              (NP (JJ NF-κB-mediated) (NN upregulation))
              (PP (IN of)
                (NP (VBG TNF-α) (NN secretion))))
            (PRN (-LRB- -LRB-)
              (CC or)
              (NX (NN vice) (NNS versa))
              (-RRB- -RRB-))))))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (NN acceleration))
            (PP (IN of)
              (NP
                (NP (NN disease) (NN onset))
                (PP (IN in)
                  (NP (NNP AA)))))))
        (PP (IN upon)
          (NP
            (NP (JJ preventive) (NN treatment))
            (PP (IN with)
              (NP (NNP RIB5/2)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN differential) (JJ clinical) (NN efficacy))
      (PP (IN of)
        (NP (JJ anti-CD4) (NNS mAbs))))
    (VP
      (VP (VBZ is) (RB not)
        (VP (VBN restricted)
          (PP (TO to)
            (NP (NN arthritis)))))
      (CC but)
      (VP (VBZ is)
        (VP
          (ADVP (RB also))
          (VBN observed)
          (PP (IN in)
            (NP (NN transplantation) (NNS models)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 37) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (SBAR (IN while)
      (S
        (NP
          (NP (JJ preventive) (NN treatment))
          (PP (IN with)
            (NP (DT the) (JJ anti-CD4) (NN mAb) (NN RIB5/2))))
        (VP (VBZ leads)
          (PP (TO to)
            (NP
              (NP (DT an) (NN acceleration))
              (PP (IN of)
                (NP (NNP AA))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (NP
        (NP (DT a)
          (ADJP (RB very) (JJ effective))
          (JJ anti-CD4) (NN mAb))
        (PP (IN for)
          (NP
            (NP (DT the) (NN induction))
            (PP (IN of)
              (NP (NN tolerance)))))
        (PP (IN in)
          (NP
            (NP (NN transplantation) (NNS models))
            (VP (VBG -LSB-)
              (NP (CD 14,37) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ indicates)
      (SBAR
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ clinical) (NN efficacy))
              (-LRB- -LRB-)
              (CC and)
              (NP (PRP$ its) (NN time) (NN course))
              (-RRB- -RRB-))
            (VP (MD may)
              (VP (VB depend)
                (PP (IN on)
                  (NP (DT the) (JJ actual) (JJ immunological) (NN constellation)))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (DT a) (VBN given) (JJ anti-CD4) (NN mAb))
            (VP (MD may)
              (VP (VB have)
                (NP (JJ beneficial) (NNS effects))
                (PP (RB only) (IN in)
                  (NP
                    (NP (JJ particular) (JJ pathologies) (NN and/or) (NNS stages))
                    (PP (IN of)
                      (NP (NN disease)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN From)
      (NP
        (NP (DT the) (NNS results))
        (PP (IN of)
          (NP (DT the) (JJ present) (NN study)))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (JJ evident))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ individual) (NNS features)
              (CC and)
              (NNS effects))
            (PP (IN of)
              (NP (DT a) (JJ particular) (JJ anti-CD4) (NN mAb))))
          (VP (VBP have)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN assessed)
                    (PP (IN before)
                      (NP (NN treatment) (NNS trials)))
                    (SBAR (IN in) (NN order)
                      (S
                        (VP (TO to)
                          (VP (VB predict)
                            (NP (PRP$ its) (JJ clinical) (NN efficacy))
                            (PP (IN in)
                              (NP (NN vivo)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (MD may)
      (VP (VB require)
        (NP (JJ several))
        (PP (IN in)
          (NP
            (NP (NN vivo))
            (, ,)
            (NP (JJ ex) (NN vivo))
            (, ,)
            (CC or)
            (NP
              (NP
                (ADJP (IN in) (NN vitro))
                (NNS assays))
              (PP (IN of)
                (NP (JJ T-cell) (NN function))))))
        (SBAR (IN in) (NN order)
          (S
            (VP (TO to)
              (VP (VB reveal)
                (NP
                  (NP (JJ subtle) (NNS differences))
                  (PP (IN between)
                    (NP (JJ anti-CD4) (NNS mAbs))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Experimental) (NNS models))
      (PP (JJ such) (IN as)
        (NP
          (NP (JJ transgenic) (NNS mice))
          (VP (VBG expressing)
            (NP
              (NP (JJ human))
              (CONJP (CC but)
                (RB not))
              (NP (NN mouse) (NN CD4)))))))
    (VP (MD may)
      (VP (VB make)
        (S
          (NP (PRP it))
          (ADJP (JJ possible)
            (S
              (VP (TO to)
                (VP (VB address)
                  (NP (JJ such) (NNS questions))
                  (PP (IN in)
                    (NP (DT the) (JJ future)
                      (QP (CD -LSB-) (CD 38))
                      (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (JJ preclinical) (NN testing))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN exploited)
          (PP (IN in)
            (NP (JJ murine)
              (ADJP
                (ADJP (JJ CD4-knockout/human) (JJ CD4-transgenic))
                (PRN (-LRB- -LRB-)
                  (ADJP (JJ huCD4-transgenic))
                  (-RRB- -RRB-)))
              (NNS systems)))
          (S
            (VP (TO to)
              (VP (VB assess)
                (NP
                  (NP (DT the) (JJ immunological) (NNS effects))
                  (PP (IN of)
                    (NP (DT a) (JJ particular) (JJ anti-human-CD4) (NN mAb))))
                (PP (IN in)
                  (NP
                    (NP (JJ various) (NN disease) (NNS models))
                    (VP (VBG -LSB-)
                      (NP (CD 39,40) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Analogous) (JJ preclinical) (NN testing))
    (VP (MD may)
      (VP (VB prove)
        (ADJP (JJ useful))
        (ADVP (RB also))
        (PP (IN for)
          (S
            (NP
              (NP (DT the) (NN comparison))
              (PP (IN of)
                (NP (JJ anti-human-CD4) (NNS mAbs))))
            (VP (VBG targeting)
              (NP (JJ distinct) (NNS epitopes)))))))
    (. .)))

(ROOT
  (S
    (NP
      (ADJP (RB Supplementary) (JJ material))
      (NNP Female) (NNP Lewis) (NNP rats)
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 8))
          (: --)
          (NP
            (NP
              (NP (CD 16) (NNS weeks))
              (ADJP (JJ old)))
            (: ;)
            (NP
              (NP (NN body) (NN weight))
              (NP (CD 150)))
            (: --)
            (NP
              (NP (CD 220))
              (NP (NN g)))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP
          (PP (IN from)
            (NP
              (NP (NNP Charles) (NNP River))
              (PRN (-LRB- -LRB-)
                (NP (NNP Sulzfeld))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-))))
          (CC or)
          (PP (IN from)
            (NP
              (NP (DT the) (NNP Medical) (NNP Experimental) (NNP Center))
              (PP (IN of)
                (NP
                  (NP (DT the) (NNP University))
                  (PP (IN of)
                    (NP (NNP Leipzig))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Female))
      (VP (VBD inbred)
        (NP (NNP Wistar))))
    (: --)
    (S
      (NP
        (NP (NNP Prob) (NNS rats))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 12))
            (: --)
            (NP (CD 16) (NNS weeks) (JJ old)))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN bred)
          (PP (IN in)
            (NP (DT the) (NNP Medical) (NNP Experimental) (NNP Center))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS animals))
    (VP (VBD were)
      (VP (VBN kept)
        (PP (IN under)
          (NP
            (NP (JJ standard) (NNS conditions))
            (, ,)
            (NP
              (NP (CD two))
              (PP (IN per)
                (NP (NN cage))))
            (, ,)))
        (PP (IN with)
          (NP
            (NP (NN food)
              (CC and)
              (NN water) (NN ad) (NN libitum))
            (CC and)
            (NP (DT a)
              (ADJP
                (NP (CD 12) (NNS h/12))
                (JJ h))
              (NN light/dark) (NN cycle))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (DT The) (NN mouse) (JJ anti-rat-CD4) (NNS mAbs))
      (SBAR
        (S
          (NP (NNP W3/25) (, ,) (NNP OX35) (, ,)
            (CC and)
            (NNP RIB5/2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNS IgG1))
              (, ,)
              (NP (NNS IgG2a))
              (, ,)
              (CC and)
              (NP
                (NP (NNS IgG2a))
                (, ,)
                (ADVP (RB respectively))))
            (-RRB- -RRB-))
          (VP (VBD were)
            (VP
              (VP (VBN used)
                (PP (IN as)
                  (NP
                    (NP (NNS ascites))
                    (ADJP (JJ fluid)
                      (PP (IN for)
                        (PP (IN in)
                          (NP (NN vivo) (NN treatment))))))))
              (CC or)
              (VP (VBN purified)
                (PP (IN on)
                  (NP (NNP Protein) (NNP A)))))))))
    (: --)
    (NP
      (NP
        (NP (NN sepharose))
        (PRN (-LRB- -LRB-)
          (PP (IN for)
            (NP (NNP OX35)
              (CC and)
              (NNP RIB5/2)))
          (-RRB- -RRB-)))
      (CC or)
      (NP (NNP Protein) (NNP G)))
    (: --)
    (NP
      (NP
        (ADJP
          (ADJP (JJ sepharose))
          (PRN (-LRB- -LRB-)
            (PP (IN for)
              (NP (NNP W3/25)))
            (-RRB- -RRB-)))
        (NNS columns))
      (PRN (-LRB- -LRB-)
        (NP (NNP Pharmacia))
        (, ,)
        (NP (NNP Freiburg))
        (, ,)
        (NP (NNP Germany))
        (-RRB- -RRB-))
      (PP (IN for)
        (NP (DT all)))
      (PP (IN in)
        (NP (JJ vitro) (NNS experiments))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ maximal) (JJ endo-toxin) (NN content))
      (PP (IN of)
        (NP (DT the) (NNS ascites))))
    (VP (VBD was)
      (NP
        (NP
          (NP (CD 58) (NN IU/ml)
            (PRN (-LRB- -LRB-)
              (NP (NNP W3/25))
              (-RRB- -RRB-)))
          (, ,)
          (NP (CD 17) (NN IU/ml)
            (PRN (-LRB- -LRB-)
              (NP (NNP RIB5/2))
              (-RRB- -RRB-)))
          (, ,)
          (CC and)
          (NP (CD 5) (NN IU/ml)
            (PRN (-LRB- -LRB-)
              (NP (NNP OX35))
              (-RRB- -RRB-))))
        (: ;)
        (S
          (NP
            (NP (DT the) (JJ final) (NN endotoxin) (NNS concentrations))
            (PP (IN for)
              (NP
                (ADJP (IN in) (NN vitro))
                (NNS experiments))))
          (VP (VBD were)
            (NP
              (QP (JJR less) (IN than) (CD 1))
              (NNP IU/ml))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NN flow) (NN cytometry)))
    (, ,)
    (NP
      (NP
        (NP
          (ADJP (RB directly) (JJ FITC-labeled))
          (NN W3/25))
        (CC and)
        (NP
          (NP (NNP OX35))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (NNS gifts))
                (PP (IN from)
                  (NP (NNP P) (NNP Kühnlein))))
              (, ,)
              (NP
                (NP (NNP Institute))
                (PP (IN of)
                  (NP (NNP Virology))))
              (, ,)
              (NP
                (NP (NNP University))
                (PP (IN of)
                  (NP (NNP Würzburg)))))
            (-RRB- -RRB-))))
      (, ,)
      (CC and)
      (NP
        (NP
          (NP (DT the) (JJ mAbs)
            (QP (CD G4) (CD .18)))
          (PRN (-LRB- -LRB-)
            (NP (JJ anti-CD3))
            (, ,)
            (NP (NNP Pharmingen))
            (, ,)
            (NP (NNP Hamburg) (, ,) (NNP Germany))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP OX8))
          (PRN (-LRB- -LRB-)
            (NP (JJ anti-CD8))
            (, ,)
            (NP (NNP Serotec))
            (, ,)
            (NP (NNP Oxford) (, ;) (NNP UK))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP OX81))
          (PRN (-LRB- -LRB-)
            (NP (JJ anti-IL4))
            (, ,)
            (NP (NNP Pharmingen))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN A5-4))
          (PRN (-LRB- -LRB-)
            (NP (JJ anti-IL-10))
            (, ,)
            (NP (NNP Pharmingen))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP
          (NP (NN DB-1))
          (PRN (-LRB- -LRB-)
            (NP (NNP anti-IFN-γ))
            (, ,)
            (NP (NNP Serotec))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN used)))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP MAbs) (NNP MOPC21))
          (PRN (-LRB- -LRB-)
            (NP (NNP IgG1))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP UPC10))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNS IgG2a))
              (, ,)
              (NP
                (NP (DT both))
                (PP (IN from)
                  (NP (NNP Sigma))))
              (, ,)
              (NP (NNP Deisenhofen) (, ,) (NNP Germany)))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP (NN mouse) (JJ anti-glucose-oxidase) (NN FITC/phycoerythrin))
          (PRN (-LRB- -LRB-)
            (NP (NNP PE))
            (-RRB- -RRB-))))
      (PRN (-LRB- -LRB-)
        (NP (NNP IgG1))
        (, ,)
        (NP (NNP IgG2a) (, ,) (NNP Dako))
        (, ,)
        (NP (NNP Hamburg) (NNP Germany))
        (-RRB- -RRB-)))
    (VP (VBD served)
      (PP (IN as)
        (NP (JJ isotype-matched) (NN control) (NNS antibodies))))
    (. .)))

(ROOT
  (FRAG
    (NP (DT The) (NN anti-TCRα))
    (: /)
    (S
      (NP (NNP β) (NNP mAb) (NNP R73))
      (VP (VBD was)
        (NP
          (NP (DT a) (NN kind) (NN gift))
          (PP (IN of)
            (NP
              (NP (NNP T) (NNP Hünig))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Institute))
                  (PP (IN of)
                    (NP (NNP Virology) (, ,) (NNP University)))
                  (PP (IN of)
                    (NP (NNP Würzburg))))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (PP (IN For)
        (NP
          (NP (NN sandwich) (NN ELISA) (NN analysis))
          (PP (IN of)
            (NP (JJ cytokine) (NNS concentrations)))))
      (, ,)
      (NP (DT the) (JJ following) (NNS antibodies))
      (VP (VBD were)
        (VP (VBN used))))
    (: :)
    (S
      (NP
        (NP (NN DB-1))
        (PRN (-LRB- -LRB-)
          (NP (NNP anti-IFN-γ))
          (-RRB- -RRB-))
        (, ,)
        (NP
          (NP
            (NP (JJ biotinylated) (NN rabbit))
            (NP
              (NP (JJ anti-rat) (NNS IFN-γ))
              (PRN (-LRB- -LRB-)
                (NP (DT both) (NNP Biosource))
                (, ,)
                (NP (NNP Ratingen))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-))))
          (: ;)
          (NP
            (NP (NN rabbit) (JJ anti-rat) (NN IL-2))
            (, ,)
            (NP
              (NP (JJ biotinylated) (NN A38-3))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (JJ anti-IL-2))
                  (, ,)
                  (NP (DT both) (NNP Pharmingen)))
                (-RRB- -RRB-)))))
        (, ,)
        (NP (NN A5-7))
        (, ,)
        (NP
          (NP
            (NP (JJ biotinylated) (NN A5-6))
            (PRN (-LRB- -LRB-)
              (NP (DT both) (NN anti-IL-10))
              (, ,)
              (NP (NNP Pharmingen))
              (-RRB- -RRB-)))
          (: ;)
          (NP
            (NP (NNP OX81))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ anti-IL-4))
              (-RRB- -RRB-))))
        (, ,))
      (VP (VBD biotinylated)
        (NP
          (NP (NN rabbit) (JJ anti-rat) (NN IL-4))
          (PRN (-LRB- -LRB-)
            (NP (NNP Biosource))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS mAbs))
    (VP (VBD were)
      (ADJP (VBN bound)
        (PP (TO to)
          (NP
            (NP (DT a) (JJ BIAcore) (NN surface))
            (PP (IN via)
              (NP
                (NP (NN goat)
                  (UCP
                    (ADJP (JJ anti-mouse) (JJ Ig-Fc))
                    (CC and)
                    (VP (VBN incubated)
                      (PP (IN with)
                        (NP
                          (NP (JJ various) (NNS concentrations))
                          (PP (IN of)
                            (NP (JJ soluble) (NN rat)))))))
                  (NN CD4))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP
                      (NP (DT a) (NN gift))
                      (PP (IN of)
                        (NP (NNP N) (NNP Barclay))))
                    (, ,)
                    (NP (NNP Oxford))
                    (, ,) (FW UK))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (NNS data))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN in)
            (NP (NN accordance)))
          (PP (IN with)
            (NP
              (NP (DT the) (NN method))
              (PP (IN of)
                (NP (NNP Karlsson)
                  (CC et)
                  (NNP al.) (NNP -LSB-) (NNP S1) (NNP -RSB-))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP
          (NP (DT the) (NN association) (NN rate))
          (NP (JJ constant) (NNS kass)))
        (, ,)
        (NP
          (NP (DT the) (NN dissociation) (NN rate))
          (NP (JJ constant) (NNS kdiss)))
        (, ,)
        (CC and)
        (NP
          (NP (DT the)
            (ADJP (RB affinity) (JJ constant))
            (NN KA))
          (PRN (-LRB- -LRB-)
            (NP (NNS kass/kdiss))
            (-RRB- -RRB-))))
      (VP (VBD were)
        (VP (VBN calculated))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Lewis) (NNS rats))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 8))
          (: --)
          (NP (CD 12) (NNS weeks) (JJ old)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN given)
        (NP (CD 0.5) (NN mg) (NN heat-inactivated))
        (NP
          (NP (NNP M.) (NNP tuberculosis))
          (PRN (-LRB- -LRB-)
            (NP (NNP Difco))
            (, ,)
            (NP (NNP Detroit))
            (, ,)
            (NP (NNP MI) (, ,) (NNP USA))
            (-RRB- -RRB-))
          (PP (IN in)
            (NP
              (NP
                (NP (CD 100) (NN μl) (NN paraffin) (NN oil))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Riedel) (NNP de) (NNP Haën))
                  (, ,)
                  (NP (NNP Seelze))
                  (, ,)
                  (NP (NNP Germany))
                  (-RRB- -RRB-)))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD was)
                    (VP (VBN injected)
                      (ADVP (RB intradermally))
                      (PP (IN into)
                        (NP
                          (NP (DT the) (NN base))
                          (PP (IN of)
                            (NP (DT the) (NN tail))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (JJ preventive) (NN treatment)))
    (, ,)
    (NP
      (NP (DT the) (NNS rats))
      (PRN (-LRB- -LRB-)
        (VP (VBN n)
          (S
            (VP (SYM =)
              (NP (CD 6))))
          (PP (IN in)
            (NP (DT each) (NN group))))
        (-RRB- -RRB-)))
    (VP (VBD received)
      (NP
        (NP
          (NP (CD 3) (NN mg))
          (PP (IN of)
            (NP (NNP RIB5/2))))
        (, ,)
        (NP
          (NP (CD 3) (NN mg))
          (PP (IN of)
            (NP (NNP W3/25))))
        (, ,)
        (CC or)
        (NP
          (NP
            (NP (CD 2) (NN mg))
            (PP (IN of)
              (NP (JJ OX35) (NN intraperitoneally))))
          (PRN (-LRB- -LRB-)
            (VP (VBN corresponding)
              (PP (TO to)
                (NP
                  (QP (CD 17.1)
                    (CC and)
                    (CD 11.4))))
              (S
                (VP (VBG mg/kg) (, ,)
                  (ADVP (RB respectively))
                  (, ,)
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN basis))
                      (PP (IN of)
                        (NP
                          (NP (DT a) (JJ mean) (NN body) (NN weight))
                          (PP (IN of)
                            (NP (CD 175) (NN g))))))))))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP
          (NP
            (NP (NNS days))
            (NP (CD -1) (, ,) (NN 0) (, ,) (CD 3) (, ,)
              (CC and)
              (CD 6))
            (, ,)
            (ADVP (RB i.e.)
              (NP (CD 1) (NN day))
              (PP (IN before)
                (NP (NNP AA) (NN induction)))))
          (, ,)
          (UCP
            (PP (IN on)
              (NP
                (NP (DT the) (NN day))
                (PP (IN of)
                  (NP
                    (NP (NN induction))
                    (PRN (-LRB- -LRB-)
                      (NP (NN day) (CD 0))
                      (-RRB- -RRB-))))))
            (, ,)
            (CC and)
            (ADVP (RB thereafter))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (JJR lower) (NN dose))
        (PP (IN of)
          (NP (NNP OX35))))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 2) (CD mg)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN chosen)
        (PP (IN on)
          (NP
            (NP (DT the) (NN basis))
            (PP (IN of)
              (NP (JJ previous) (NNS experiments)))))
        (S
          (VP (VBG demonstrating)
            (NP (PRP$ its) (JJ high) (JJ clinical) (NN efficacy))
            (PP (IN in)
              (NP (NNP AA) (NNP -LSB-) (NNP S2) (NNP -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN control) (NN group))
    (VP (VBD received)
      (NP (NNP PBS) (NNP -LSB-) (NNP S3) (NNP -RSB-)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (JJ preventive) (NN treatment))
      (PP (IN with)
        (NP
          (NP (DT an) (JJ isotype-matched) (NN mAb))
          (PP (IN from)
            (NP (NN birth))))))
    (VP (VBD had)
      (VP (VBN shown)
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (NNP rat) (NNP AA))
            (PP (IN in)
              (NP (DT a) (JJ previous) (NN study) (NNP -LSB-) (NNP S3) (NNP -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (NN determination))
        (PP (IN of)
          (NP (DT the) (NN arthritis) (NN score)))))
    (, ,)
    (NP (DT each) (NN paw))
    (VP (VBD was)
      (VP (VBN graded)
        (PP (VBG according)
          (PP (TO to)
            (NP
              (NP (DT the) (NN extent))
              (PP (IN of)
                (NP
                  (NP (NN erythema)
                    (CC and)
                    (NN edema))
                  (PP (IN of)
                    (NP (DT the) (NN periarticular) (NN tissue)))
                  (, ,)
                  (PP (IN on)
                    (NP
                      (NP (DT a) (NN scale))
                      (PP (IN of)
                        (NP
                          (NP (CD 0) (: --) (CD 4))
                          (, ,)
                          (SBAR
                            (WHADVP (WRB where))
                            (S
                              (NP
                                (NP
                                  (NP (CD 0))
                                  (SBAR
                                    (S
                                      (VP (SYM =)
                                        (NP (DT no) (NN inflammation))))))
                                (, ,)
                                (NP
                                  (NP
                                    (QP (CD 1) (CD =))
                                    (JJ unequivocal) (NNS inflammation))
                                  (PP (IN of)
                                    (NP (CD one) (NN paw) (NN joint))))
                                (, ,)
                                (NP
                                  (NP
                                    (QP (CD 2) (CD =))
                                    (JJ unequivocal) (NNS inflammation))
                                  (PP (IN of)
                                    (NP
                                      (NP
                                        (QP (IN at) (JJS least) (CD two))
                                        (JJ paw) (NNS joints))
                                      (CC or)
                                      (NP
                                        (NP (JJ moderate) (NN inflammation))
                                        (PP (IN of)
                                          (NP (CD one) (NN paw) (NN joint)))))))
                                (, ,)
                                (NP
                                  (NP
                                    (QP (CD 3) (CD =))
                                    (JJ severe) (NNS inflammation))
                                  (PP (IN of)
                                    (NP
                                      (QP (CD one)
                                        (CC or)
                                        (JJR more))
                                      (NN paw) (NNS joints))))
                                (, ,)
                                (CC and)
                                (NP (CD 4)))
                              (VP (SYM =)
                                (NP (JJ maximum) (NN inflammation)))))))
                      (PP (IN of)
                        (NP
                          (NP
                            (QP (CD one)
                              (CC or)
                              (JJR more))
                            (JJ paw) (NNS joints))
                          (ADJP
                            (NP (NNP -LSB-) (CD S4) (, ,) (CD S5))
                            (JJ -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS scores))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN added)
        (S
          (VP (TO to)
            (VP (VB obtain)
              (NP
                (NP (DT the) (JJ total) (NN score))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ maximal) (JJ possible) (NN score))
                    (PP (IN of)
                      (NP (CD 16)))
                    (PP (IN for)
                      (NP (DT each) (NN animal))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (NN determination))
        (PP (IN of)
          (NP (NN cell) (NN depletion)
            (CC and)
            (NN modulation)))
        (PP (IN of)
          (NP (NN surface) (NNS molecules)))))
    (, ,)
    (NP
      (NP (NN blood) (NNS samples))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 100) (CD μl)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN taken)
        (PP (IN via)
          (NP (JJ retro-orbital) (NN puncture)))
        (PP (IN on)
          (NP
            (NP (NN day) (CD 8))
            (CC or)
            (NP (NN day) (CD 13))))
        (PP (IN after)
          (NP
            (NP (NN induction))
            (PP (IN of)
              (NP (NNP AA)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Whole-blood) (NNS cells))
    (VP (VBD were)
      (VP (VBN stained)
        (PP (IN with)
          (NP
            (NP
              (NP (VBG saturating) (NNS amounts))
              (PP (IN of)
                (NP (RB directly) (JJ FITC-labeled) (NNP W3/25) (, ,) (NNP OX35) (, ,) (NNP G4) (CD .18) (, ,) (CD OX8) (, ,))))
            (CC or)
            (NP
              (NP (JJ respective) (NN isotype))
              (, ,)
              (VP (VBN followed)
                (PP (IN by)
                  (NP (JJ erythrocyte) (NNS lysis)))))))))
    (. .)))

(ROOT
  (S
    (NP (CD Ten) (CD thousand) (NNS events))
    (VP (VBD were)
      (VP (VBN analyzed)
        (S
          (VP (VBG using)
            (NP
              (NP
                (NP (DT an) (NNP Epics) (NNP XL) (NN flow) (NN cytometer))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Coulter))
                  (, ,)
                  (NP (NNP Krefeld))
                  (, ,)
                  (NP (NNP Germany))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (DT the) (NNS results))
                (VP (VBN displayed)
                  (PP (IN as)
                    (NP (NNS histograms))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB assess)
          (NP (DT the) (NNP DTH)))))
    (, ,)
    (NP
      (NP (DT either) (CD 10) (NN μg))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ arthritogen) (NNP M.) (NNP tuberculosis))
          (PP (IN in)
            (NP
              (NP (CD 50) (NN μl) (NNP PBS))
              (, ,)
              (CC or)
              (NP (CD 50) (NNP μl) (NNP PBS) (RB only))
              (, ,))))))
    (VP (VBD were)
      (VP (VBN injected)
        (ADVP (RB intradermally))
        (PP (IN into)
          (NP
            (NP (DT the) (NN pinna))
            (PP (IN of)
              (NP
                (NP (DT the) (NN left))
                (CC or)
                (NP (DT the) (JJ right) (NN ear))))))
        (, ,)
        (ADVP (RB respectively))
        (, ,)
        (PP (IN on)
          (NP
            (NP (NN day) (CD 13))
            (PP (IN after)
              (NP
                (NP (NN induction))
                (PP (IN of)
                  (NP (NNP AA)))))))))
    (. .)))

(ROOT
  (S
    (PP
      (NP (CD One) (NN day))
      (IN after)
      (NP (NN injection)))
    (, ,)
    (NP
      (NP (DT the) (VBG swelling))
      (PP (IN of)
        (NP (DT the) (NNS ears))))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN with)
          (NP
            (NP (DT a) (NN gauge))
            (PRN (-LRB- -LRB-)
              (NP (NNP Hahn)
                (CC &)
                (NNP Kolb))
              (, ,)
              (NP (NNP Stuttgart))
              (, ,)
              (NP (NNP Germany))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Swelling))
    (VP (VBD was)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP
              (NP (DT the) (NN difference))
              (PRN (-LRB- -LRB-)
                (NP (NN mm))
                (-RRB- -RRB-)))
            (PP (IN between)
              (NP
                (NP (DT the) (NN thickness))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN left))
                    (CC and)
                    (NP (DT the) (JJ right) (NN ear))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN purified)
        (PP (IN from)
          (NP (NNS spleens)))
        (SBAR (IN as)
          (S
            (VP (VBD described)
              (ADVP (RB elsewhere)
                (NP
                  (QP (CD -LSB-) (CD S6))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (S
      (NP (DT the) (NNS spleens))
      (VP (VBD were)
        (VP (VBN passed)
          (PP (IN through)
            (NP (DT a) (JJ stainless) (NN steel) (NN sieve))))))
    (CC and)
    (S
      (NP (DT the) (VBG resulting) (NN suspension))
      (VP (VBD was)
        (VP (VBN centrifuged)
          (PP (IN through)
            (NP
              (NP (NNP Lymphoprep))
              (PRN (-LRB- -LRB-)
                (NP (NNP Pharmacia))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Cells))
      (VP (VBN contained)
        (PP (IN in)
          (NP (DT the) (NN interphase)))))
    (VP (VBD were)
      (ADVP (RB then))
      (VP
        (VP (VBN washed)
          (ADVP (RB twice)))
        (CC and)
        (VP (VBN loaded)
          (PP (IN onto)
            (NP
              (NP (DT a) (JJ 10-ml) (NN syringe))
              (PP (IN with)
                (NP
                  (NP
                    (QP (CD 1.2) (CD g))
                    (NN nylon) (NN wool))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Polyscience))
                    (, ,)
                    (NP (NNP Eppelheim))
                    (, ,)
                    (NP (NNP Germany))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN for)
          (NP
            (NP (CD 1) (NN hour))
            (PP (IN at)
              (NP
                (NP (CD 37) (NNP °) (NNP C))
                (, ,)
                (NP
                  (ADJP (CD 5) (NN %))
                  (NN CO2))))))))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP (VBN eluted)
        (PP (IN with)
          (NP
            (S
              (VP (VBG RPMI)
                (NP (JJ 1640/GlutaMaxI) (JJ con)
                  (PRN (: -)
                    (VP (VBG taining)
                      (NP
                        (NP (CD 10) (NN %) (NN FCS))
                        (, ,)
                        (NP (CD 15) (NN mM) (NNS HEPES))
                        (, ,)
                        (NP (CD 100) (JJ U/ml) (NN penicillin))
                        (, ,)
                        (CC and)
                        (NP (CD 100) (NN μg))))
                    (: /))
                  (NN ml) (NN streptomycin))))
            (PRN (-LRB- -LRB-)
              (VP
                (ADVP (RB thereafter))
                (VBN called)
                (NP
                  (NP (NNP R10F))
                  (, ,)
                  (NP
                    (NP (DT all))
                    (PP (IN from)
                      (NP (NNP GIBCO-BRL))))
                  (, ,)
                  (NP (NNP Eggenstein) (, ,) (NNP Germany))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ resulting) (JJ total) (NN T-cell) (NN suspension))
    (VP (VBD was)
      (VP (VBG ≥)
        (NP (CD 95) (NN %))
        (NP
          (NP (NNP CD3) (NNP +))
          (, ,)
          (SBAR (IN as)
            (S
              (VP (VBN evaluated)
                (PP (IN by)
                  (NP (NN flow) (NN cytometry)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT Either) (JJ purified) (JJ total) (NNP T) (NNS cells))
      (VP (VBD were)
        (ADVP (RB directly))
        (VP (VBN used)
          (PP (IN for)
            (NP (NN proliferation) (NNS assays))))))
    (, ,)
    (CC or)
    (S
      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
      (VP (VBD were)
        (ADVP (RB first))
        (VP
          (VP
            (ADVP (RB negatively))
            (VBN purified)
            (PP (IN by)
              (S
                (VP (VBG adding)
                  (NP (CD 5) (NN μg))))))
          (PRN (: /)
            (NP
              (NP
                (QP (CD 1) (CD ×))
                (CD 107) (NNS cells))
              (SBAR
                (S
                  (NP (NNP OX8))
                  (VP (VBP mAb)
                    (PP (IN for)
                      (NP (CD 30) (NN min))))))
              (PP (IN on)
                (NP (NN ice)))))
          (CC and)
          (, ,)
          (PP (IN after)
            (NP
              (NP (NNP washing))
              (, ,)
              (NP
                (NP (CD 75) (NN μl) (NNS Dynabeads-M450))
                (VP (VBN coupled)
                  (PP (TO to)
                    (NP
                      (NP (NN goat) (JJ anti-mouse) (NN IgG))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Dynal))
                        (, ,)
                        (NP (NNP Hamburg))
                        (, ,)
                        (NP (NNP Germany))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN suspension))
    (VP (VBD was)
      (ADVP (RB again))
      (VP
        (VP (VBN incubated)
          (PP (IN for)
            (NP
              (NP (CD 30) (NN min))
              (PP (IN on)
                (NP (NN ice))))))
        (CC and)
        (VP
          (ADVP (RB then))
          (VBN separated)
          (PP (IN by)
            (NP
              (NP (DT a) (JJ magnetic) (NN particle) (NN concentrator))
              (PRN (-LRB- -LRB-)
                (NP (NNP MPC) (NNP ®))
                (, ,)
                (NP (NNP Dynal))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN purity))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNP T-cell) (NNS populations))))
    (VP (VBD was)
      (VP
        (ADVP (RB always))
        (VBG ≥)
        (NP (CD 95) (NN %))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN assessed)
              (PP (IN by)
                (NP (NN flow) (NN cytometry))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (NN enrichment))
        (PP (IN of)
          (NP
            (NP (JJ dendritic) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNP DC))
              (-RRB- -RRB-))))))
    (, ,)
    (NP
      (NP (NNS suspensions))
      (PP (IN of)
        (NP
          (NP (NN spleen) (NNS cells))
          (PP (IN from)
            (NP (JJ healthy) (NNS rats))))))
    (VP (VBD were)
      (VP
        (VP (VBN subjected)
          (PP (TO to)
            (NP
              (NP (DT an) (JJ overnight) (NN adhesion) (NN step))
              (PP (IN on)
                (NP
                  (NP (NNP Petri) (NNS dishes))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Falcon) (NNP ®))
                    (, ,)
                    (NP (NNP Becton) (NNP Dickinson))
                    (, ,)
                    (NP (NNP Heidelberg) (, ,) (NNP Germany))
                    (-RRB- -RRB-)))))))
        (CC and)
        (VP
          (ADVP (RB then))
          (VBN centrifuged)
          (PP (IN through)
            (NP
              (NP (CD 2) (NN ml))
              (PP (IN of)
                (NP
                  (NP (DT a)
                    (ADJP
                      (NP (CD 14.5) (NN %))
                      (JJ metrizamide))
                    (NN solution))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Sigma))
                    (-RRB- -RRB-))))))
          (PP (IN in)
            (NP (NNP R10F))))))
    (. .)))

(ROOT
  (S
    (NP (NNP DC))
    (VP (VBD were)
      (VP
        (ADVP (RB then))
        (VBN irradiated)
        (PP (IN with)
          (NP (CD 15) (NNS Gy)))
        (S
          (VP (TO to)
            (VP (VB prevent)
              (NP (PRP$ their) (NN proliferation))
              (PP (IN in)
                (NP (JJ subsequent) (NNS assays))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NN proliferation) (NNS assays)))
    (, ,)
    (NP
      (NP (CD 1)
        (ADJP
          (QP (CD ×) (CD 105)))
        (JJ purified)
        (UCP
          (ADJP (JJ total))
          (CC or)
          (NP (NNP CD4) (NNP +)))
        (JJ spleen) (NN T) (NNS cells))
      (PP (IN per)
        (NP
          (NP (NN well))
          (PP (IN of)
            (NP (JJ 96-well) (JJ round-bottom) (NNS plates))))))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP (CD 1) (NNP ×) (CD 104) (NNP DC))
            (PP (IN per)
              (NP
                (UCP
                  (ADVP (RB well))
                  (CC and)
                  (PP
                    (NP
                      (NP (CD 1) (NN μg)
                        (PRN (: /)
                          (ADVP (RB ml))
                          (NP (NNP ConA))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Sigma))
                        (-RRB- -RRB-)))
                    (IN for)
                    (NP (CD 72))))
                (NNS hours)))))))
    (. .)))

(ROOT
  (S (RB Then)
    (NP
      (NP (CD 1) (NN μCi)
        (PRN (: /)
          (ADVP (RB well))
          (NP (JJ 3H-thymidine))))
      (PRN (-LRB- -LRB-)
        (NP (NNP Amersham-Buchler))
        (, ,)
        (NP (NNP Braunschweig))
        (, ,)
        (NP (NNP Germany))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN added)))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (DT an) (JJ additional) (NN incubation))
        (PP (IN for)
          (NP (CD 16) (NNS hours)))))
    (, ,)
    (S
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN harvested)
          (PP (IN onto)
            (NP (NN fiber) (NNS filters))))))
    (CC and)
    (S
      (NP (JJ cell-bound) (NN radioactivity))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP
              (NP (JJ β-scintillation) (NN counting))
              (PRN (-LRB- -LRB-)
                (NP (NNP Matrix96) (NNP ®))
                (, ,)
                (NP (NNP Canberra) (NNP Packard))
                (, ,)
                (NP (NNP Dreieich) (, ,) (NNP Germany))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Total) (NNP T) (NNS cells))
        (CC or)
        (NP (NNP purified) (NNP CD4)))
      (VP (VBD +)
        (NP (NNP T) (NNS cells))
        (PP (IN from)
          (NP
            (NP (NNS spleens))
            (PP (IN of)
              (NP (JJ healthy) (NNP Lewis) (NNS rats)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP
          (NP (JJ allogeneic) (NNS DC))
          (PP (IN from)
            (NP
              (NP (NNS spleens))
              (PP (IN of)
                (NP (NNP Wistar))))))
        (: --)
        (NP (NNP Prob) (NNS rats))
        (, ,))
      (VP (VBD were)
        (VP (VBN prepared)
          (SBAR (IN as)
            (S
              (VP (VBD described)
                (ADVP (RB above))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Total)
      (CC or)
      (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP (VBN seeded)
        (PP (IN at)
          (NP
            (NP (CD 4) (JJ ×) (CD 105) (NNS cells))
            (PP (IN per)
              (FRAG
                (PP
                  (ADVP (RB well))
                  (PP (IN in)
                    (NP (JJ 96-well) (JJ flat-bottom) (NNS plates)))
                  (, ,)
                  (ADVP (RB together))
                  (PP (IN with)
                    (NP
                      (NP (CD 1) (, ,) (CD 2) (, ,)
                        (CC or)
                        (CD 4))
                      (SBAR
                        (S
                          (NP
                            (NP (NNP ×) (NNP 104) (NNP DC))
                            (PP (IN per)
                              (NP
                                (NP (NN well))
                                (CC and)
                                (NP (CD 1) (, ,) (CD 5) (, ,)
                                  (CC or)
                                  (CD 10)))))
                          (VP (VBP μg)
                            (NP
                              (NP (JJ /) (NN ml))
                              (PP (IN of)
                                (NP (DT the) (JJ respective) (JJ purified) (JJ anti-CD4) (NN mAb)))))))
                      (PRN (-LRB- -LRB-)
                        (CC or)
                        (S
                          (NP (JJ isotype) (NN control))
                          (VP (VBZ mAbs)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN for)
          (NP
            (NP (CD 72) (NNS hours))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 37) (NNP °) (NNP C))
                (, ,)
                (NP (CD 5) (NN %) (NN CO2)))
              (-RRB- -RRB-))))))
    (, ,)
    (S
      (NP
        (NP (NN bromodeoxyuridine))
        (PRN (-LRB- -LRB-)
          (NP (NNP BrdU))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN added))))
    (CC and)
    (S
      (NP (NN incubation))
      (VP (VBD was)
        (VP (VBN continued)
          (PP (IN for)
            (NP (DT an) (JJ additional) (CD 16) (NNS hours))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN proliferation))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN by)
          (NP
            (NP
              (NP (DT a) (NNP BrdU) (NNP cell-proliferation) (NNP ELISA))
              (PRN (-LRB- -LRB-)
                (NP (NNP Boehringer) (NNP Mannheim))
                (, ,)
                (NP (NNP Mannheim))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP (NN accordance)))))
        (PP (IN with)
          (NP
            (NP (DT the) (NN supplier) (POS 's))
            (NNS recommendations)))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (JJ anti-CD4) (NN preincubation)))
    (, ,)
    (NP (JJ spleen) (NNP CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (DT the) (JJ anti-CD4) (NNS mAbs))
                  (CC or)
                  (NP (JJ isotype) (NN control) (NNS mAbs)))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 10) (NN μg))
                    (PP (IN per)
                      (NP (CD 1) (VBG ×) (CD 107) (NNS cells))))
                  (-RRB- -RRB-)))
              (PP (IN for)
                (NP
                  (NP (CD 30) (NN min))
                  (PP (IN at)
                    (NP (CD 4) (NN °) (NNP C))))))))
        (CC and)
        (VP (VBN washed)
          (ADVP (RB once)))))
    (. .)))

(ROOT
  (S
    (NP (DT The)
      (ADJP (VBN bound))
      (NNS mAbs))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN cross-linked)
        (PP (IN with)
          (NP
            (NP
              (NP (NN goat) (JJ anti-mouse) (NN IgG))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (NP
                    (NP (NNP Jackson) (NNP Lab))
                    (, ,)
                    (NP (CD 20) (NN μg)))
                  (: /)
                  (NP
                    (NP (CD 1))
                    (NP
                      (QP (CD ×) (CD 107))
                      (NNS cells))))
                (-RRB- -RRB-)))
            (PP (IN for)
              (NP (CD 1) (NN hour)))))
        (PP (IN at)
          (NP (CD 37) (NN °) (NNP C)))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG washing))))
    (, ,)
    (NP
      (NP (DT the) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 1) (NNP ×) (CD 106))
          (PP
            (PP (IN per)
              (NP (NN ml)))
            (CC and)
            (PP (IN per)
              (ADVP (RB well)))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN seeded)
        (PP (IN in)
          (NP
            (NP (JJ 24-well) (NNS plates))
            (VP
              (VP
                (ADVP (RB previously))
                (VBN coated)
                (PP (IN with)
                  (NP (NNP R73))))
              (CC and)
              (VP (VBN harvested)
                (PP (IN after)
                  (NP (CD 24)
                    (CC and)
                    (CD 48) (NNS hours)))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Anti-CD4-preincubated) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN washed))
        (, ,)
        (VP (VBN fixed)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD 4) (NN %))
                (NN paraformaldehyde))
              (PP (IN in)
                (NP (NNP PBS))))))
        (, ,)
        (VP (VBN permeabilized)
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP
                  (ADJP (CD 0.5) (NN %))
                  (NN saponin))
                (PP (IN in)
                  (NP (NNP PBS))))
              (, ,)
              (NP
                (NP
                  (NP (CD 1) (NN %))
                  (NP (NNP FCS))
                  (, ,)
                  (NP
                    (NP (CD 0.01) (NN %))
                    (NP (NNS NaN3)))
                  (: ;))
                (PP (IN for)
                  (NP (DT this) (NN step))))
              (, ,)
              (NP
                (NP (NN supplemented))
                (PP (IN with)
                  (NP
                    (ADJP (CD 10) (NN %))
                    (NN rat) (NN serum)))))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (VP (VBN incubated)
          (PP (IN with)
            (NP (CD 1) (NN μg) (NNP anti-IFN-γ) (NNP FITC) (, ,) (JJ anti-IL-4) (NNP PE) (, ,) (JJ anti-IL-10) (NNP PE))))
        (, ,)
        (CC or)
        (VP
          (ADVP (RB directly))
          (VBN labeled)
          (NP (JJ isotype-control) (NNS mAbs))
          (SBAR (IN for)
            (S
              (NP
                (NP (CD 30) (NN min))
                (PP (IN at)
                  (NP (CD 4) (JJ °) (NNP C.) (NNP FACS) (NN analysis))))
              (VP (VBD was)
                (VP (VBN performed)
                  (S
                    (VP (VBG using)
                      (NP
                        (NP (DT a) (NNP FACScan) (NNP ®) (NN flow) (NN cytometer))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Becton) (NNP Dickinson))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Detection))
      (PP (IN of)
        (NP (NNP TNF-α))))
    (VP (VBD was)
      (VP (VBN performed)
        (S
          (VP (VBG using)
            (NP
              (NP (DT a) (NN bioassay))
              (VP (VBN based)
                (PP (IN on)
                  (NP
                    (NP (DT the) (NNS lysis))
                    (PP (IN of)
                      (NP (DT the) (NNP WEHI164/13) (NN cell) (NN line)))))
                (PP (IN after)
                  (NP (NN exposure)))
                (PP (TO to)
                  (NP (NNP TNF-α)))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Assay) (NN specificity))
    (VP (VBD was)
      (VP (VBN ensured)
        (PP (IN by)
          (S
            (VP (VBG adding)
              (NP (DT a) (JJ neutralizing) (NN mAb))
              (S
                (VP (TO to)
                  (VP (VB rat)
                    (NP (NNS TNF-α))
                    (FRAG (-LRB- -LRB-)
                      (NP (CD 100) (NN μg))
                      (: /)
                      (NP
                        (NP (NN ml))
                        (: ;)
                        (NP
                          (NP (NN clone))
                          (NP (CD 45418.111)))
                        (: ;)
                        (NP (NNP R&D) (NNP Systems) (, ,) (NNP Wiesbaden) (, ,) (NNP Germany)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Culture) (NNS supernatants))
    (VP (VBD were)
      (VP (VBN analyzed)
        (PP (IN for)
          (NP
            (NP (CD IFN-γ) (, ,) (NN IL-2) (, ,) (NN IL-4) (, ,)
              (CC and)
              (NN IL-10))
            (PP (IN by)
              (NP (NNP sandwich) (NNP ELISA)))))
        (PP (IN with)
          (NP
            (NP (DT the) (JJ above-mentioned) (NN capture))
            (CC and)
            (NP (NN detection) (NNS antibodies))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Recombinant) (NN cytokine) (NNS standards))
      (VP (VBD were)
        (NP
          (SBAR (IN as)
            (S
              (VP (VBZ follows))))
          (: :)
          (NP
            (NP
              (NP (NNP IFN-γ))
              (PRN (-LRB- -LRB-)
                (NP (NNP Laboserv))
                (-RRB- -RRB-)))
            (, ,)
            (ADJP (JJ IL-2) (, ,) (JJ IL-10))
            (, ,)
            (CC and)
            (NP
              (NP (NN IL-4))
              (PRN (-LRB- -LRB-)
                (NP (NNP Pharmingen))
                (-RRB- -RRB-)))))))
    (: ;)
    (S
      (NP
        (NP (NN range))
        (PP (IN for)
          (NP (NNP IFN-γ) (, ,) (NNP IL-2) (, ,)
            (CC and)
            (NNP IL-10))))
      (VP (VBD was)
        (NP
          (NP (CD 39))
          (: --)
          (ADJP (CD 5000) (JJ pg/ml)))))
    (: ;)
    (S
      (NP
        (NP (NN range))
        (PP (IN for)
          (NP (NN IL-4))))
      (VP (VBD was)
        (ADJP (JJ 9.85))))
    (: --)
    (S
      (NP (CD 1250))
      (VP (VBP pg/ml)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Cytokine) (NNS concentrations))
      (PP (IN in)
        (NP (DT the) (NN culture) (NNS supernatants))))
    (VP (VBD were)
      (VP (VBN calculated)
        (PP (IN from)
          (NP
            (NP (DT a) (JJ standard) (NN curve))
            (VP (VBG using)
              (NP
                (NP (DT the) (NN software) (NN EasyFit))
                (PRN (-LRB- -LRB-)
                  (NP (NNP SLT))
                  (, ,)
                  (NP (NNP Crailsheim))
                  (, ,)
                  (NP (NNP Germany))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Purified) (NN spleen) (CD CD4) (NNP +) (NNP T) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN preincubated)
          (PP (IN with)
            (NP (DT the) (JJ anti-CD4) (NNS mAbs)))
          (ADVP
            (ADVP (RB as) (JJ above))
            (CC and)
            (ADVP (RB then))))
        (CC either)
        (VP (VBN stimulated)
          (PP
            (PP (IN on)
              (NP
                (NP (JJ anti-CD3) (JJ mAb-precoated) (JJ 6-well) (NNS plates))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 1) (JJ ×) (CD 107) (NNS cells))
                    (PP (IN per)
                      (NP (NN well))))
                  (-RRB- -RRB-))))
            (CC or)
            (PP (IN with)
              (NP
                (NP (DT a) (NN combination))
                (PP (IN of)
                  (NP
                    (NP (JJ phorbol) (JJ myristoyl) (NN acetate))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP PMA))
                        (: ;)
                        (NP (CD 10) (NN ng/ml)))
                      (-RRB- -RRB-))
                    (CC and)
                    (NP (NN ionomycin))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 250) (CD ng/ml)))
                      (-RRB- -RRB-))))
                (PP (IN for)
                  (NP
                    (NP (CD 4) (NNS hours))
                    (PP (IN at)
                      (NP (CD 37)))))))
            (NP (NNP °) (NNP C))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (NN stimulation)))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN washed)
          (ADVP (RB once))
          (PP (IN with)
            (NP (NNP PBS))))
        (CC and)
        (VP (VBN microcentrifuged)
          (PRN (-LRB- -LRB-)
            (NP (CD 10,000) (NN ×) (NN g))
            (-RRB- -RRB-)))
        (PP (IN at)
          (NP
            (NP (CD 4) (NNP °) (NNP C))
            (PP (IN for)
              (NP (CD 1) (NN min)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN pellet))
    (VP (VBD was)
      (VP
        (VP (VBN resuspended)
          (PP (IN in)
            (NP
              (NP
                (QP (CD 400) (CD μl))
                (JJ ice-cold) (NN buffer) (NN A))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 10) (NN mM) (NNS HEPES))
                  (, ,)
                  (NP (CD 10) (NN mM) (NNP KCl))
                  (, ,)
                  (NP (CD 0.1) (NN mM) (NNP EDTA))
                  (, ,)
                  (NP (CD 0.1) (NN mM) (NNP EGTA))
                  (, ,)
                  (NP (CD 0.5) (NN mM) (NNP PMSF))
                  (, ,)
                  (NP (CD 1) (NN mM) (NN dithiothreitol))
                  (, ,)
                  (CC and)
                  (NP (CD 1) (NN mM) (NNS Na3VO4)))
                (-RRB- -RRB-)))))
        (CC and)
        (VP (VBN placed)
          (PP (IN on)
            (NP
              (NP (NN ice))
              (PP (IN for)
                (NP (CD 15) (NN min))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Subsequently))
    (, ,)
    (S
      (NP
        (NP (CD 25) (NN μl))
        (PP (IN of)
          (NP
            (NP (DT a)
              (ADJP (CD 10) (NN %))
              (NNP Nonidet) (NNP P-40) (NN solution))
            (PRN (-LRB- -LRB-)
              (NP (NNP Boehringer) (NNP Mannheim))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (NN sample))))))
    (CC and)
    (S
      (NP (DT the) (NNS cells))
      (VP (VBD were)
        (VP (VBN homogenized)
          (PP (IN by)
            (S
              (VP (VBG vortexing)
                (SBAR (IN for)
                  (S
                    (NP (CD 30))
                    (VP (VBZ s)
                      (VP (VBN followed)
                        (PP (IN by)
                          (NP
                            (NP (NN microcentrifugation))
                            (PP (IN for)
                              (NP (CD 1) (NN min)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ nuclear) (NNS pellets))
    (VP (VBD were)
      (VP
        (VP (VBN resuspended)
          (PP (IN in)
            (NP
              (NP (CD 50) (NN μl))
              (PP (IN of)
                (NP
                  (NP (NNP buffer) (NNP B))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 20) (NN mM) (NNS HEPES))
                      (, ,)
                      (NP (CD 400) (NN mM) (NNP NaCl))
                      (, ,)
                      (NP (CD 0.1) (NN mM) (NNP EDTA))
                      (, ,)
                      (NP (CD 0.1) (NN mM) (NNP EGTA))
                      (, ,)
                      (NP (CD 2) (NN mM) (NNP PMSF))
                      (, ,)
                      (NP (CD 1) (NN mM) (NN dithiothreitol))
                      (, ,)
                      (CC and)
                      (NP (CD 1) (NN mM) (NNS Na3VO4)))
                    (-RRB- -RRB-)))))))
        (CC and)
        (VP (VBN shaken)
          (PP (IN for)
            (NP
              (NP (CD 15) (NN min))
              (PP (IN at)
                (NP (CD 4) (NN °) (NNP C))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN microcentrifugation))
        (PP (IN for)
          (NP
            (NP (CD 5) (NN min))
            (PP (IN at)
              (NP (CD 4) (NN °) (NNP C)))))))
    (, ,)
    (NP (DT the) (NNS supernatants))
    (VP (VBD were)
      (VP (VBN aliquoted)
        (CC and)
        (VBN stored)
        (PP (IN at)
          (NP (NNP -70) (NNP °) (NNP C)))
        (PP (IN until)
          (NP (JJ further) (NN use)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ nuclear) (NNS extracts))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 10) (CD μg))
          (NN total) (NN protein))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (ADVP (IN than))
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP
              (NP
                (NP
                  (NP (CD 2) (JJ ×) (CD 108) (NNS cpm))
                  (PP (IN of)
                    (NP
                      (NP (JJ 32P-labeled) (, ,) (JJ double-stranded) (JJ oligonucleotide) (NN probe) (-LRB- -LRB-) (NN sense) (NN strand) (RB only))
                      (: ;)
                      (NP (CD AP-1) (: :) (CD 5))
                      ('' '))))
                (: -)
                (NP
                  (NP (NNP CGC) (NNP TTG) (NNP ATG) (NNP AGT) (NNP CAG))
                  (NP (NNP CCG) (NNP GAA-3) (POS ')))
                (: ;)
                (NP
                  (NP (NNP NF-κB))
                  (: :)
                  (NP
                    (NP (CD 5) (POS '))
                    (NNP -) (NNP AGT) (NNP TGA) (NNP GGG) (NNP GAC) (NNP TTT) (NNP CCC) (NNP AGG) (NNP C-3) ('' ')))
                (: ;)
                (NP
                  (NP (DT both))
                  (PP (IN from)
                    (NP
                      (NP (NNP Promega) (, ,) (NNP Mannheim) (, ,) (NNP Germany))
                      (: ;)
                      (NP (CD NF-AT) (: :) (CD 5))
                      ('' '))))
                (: -)
                (NP
                  (NP (NNP CGC) (NNP CCA) (NNP AAG) (NNP AGG) (NNP AAA) (NNP ATT) (NNP TGT))
                  (NP (NNP TTC) (NNP ATA-3) (POS ')))
                (: ;)
                (NP
                  (NP (NNP Santa) (NNP Cruz))
                  (, ,)
                  (NP (NNP Heidelberg))))
              (, ,)
              (NP (NNP Germany))
              (-RRB- -RRB-))
            (PP (IN in)
              (NP
                (NP
                  (NP (CD 25) (JJ μl) (JJ binding) (NN buffer))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 1) (NNP M) (NNPS Tris))
                      (, ,)
                      (NP (CD 1) (NNP M) (NN boric) (NN acid))
                      (, ,)
                      (NP (NNP 0.02) (NNP M) (NNP EDTA))
                      (, ,)
                      (NP (CD 5) (NN %) (NN glycerol)))
                    (-RRB- -RRB-)))
                (UCP
                  (VP (VBN supplemented)
                    (PP (IN with)
                      (NP
                        (NP
                          (ADJP (RB poly) (JJ -LSB-))
                          (JJ dI-dC) (NNS -RSB-))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 0.16) (NN mg/ml) (NN Pharmacia))
                          (-RRB- -RRB-)))))
                  (CC and)
                  (ADJP
                    (NP (CD 2) (NNS mM))
                    (JJ dithiothreitol)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS samples))
    (VP (VBD were)
      (VP (VBN separated)
        (PP (IN on)
          (NP
            (NP (DT a)
              (ADJP (CD 4) (NN %))
              (NN polyacrylamide) (NN gel))
            (PP (IN at)
              (NP
                (QP (CD 200) (CD V))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG scanning)
          (PP (IN in)
            (NP
              (NP (DT a) (NN phosphor) (NN imager))
              (PRN (-LRB- -LRB-)
                (NP (NNP BAS-1000))
                (, ,)
                (NP (NNP Fuij) (NNP Photo) (NNP Film) (NNP Co.) (NNP Ltd))
                (, ,)
                (NP (NNP Japan))
                (-RRB- -RRB-)))))))
    (, ,)
    (NP (DT the) (NNS bands))
    (VP (VBD were)
      (VP (VBN quantified)
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (NNP PCBAS) (CD 2.09) (NN g) (NN software))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fuij) (NNP Photo) (NNP Film) (NNP Co.) (NNP Ltd))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNS Differences))
        (PP (IN between)
          (NP (JJ experimental) (NNS groups))))
      (VP (VBD were)
        (VP (VBN evaluated)
          (PP (IN with)
            (NP (DT the) (JJ two-tailed) (JJ nonparametric) (NN Mann))))))
    (: --)
    (S
      (NP
        (NP (NNP Whitney))
        (PRN (-LRB- -LRB-)
          (NP (NNP U))
          (-RRB- -RRB-)))
      (VP (VBP test)))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP Spearman) (NN rank) (NN correlation) (NN test))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB verify)
              (SBAR (IN whether)
                (S
                  (NP
                    (NP (DT the) (JJ ex) (JJ vivo) (JJ 3H-thymidine) (NN uptake))
                    (PP (IN of)
                      (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
                  (VP (VBD correlated)
                    (PP (IN with)
                      (NP
                        (NP (DT the) (NN arthritis) (NN score))
                        (PP (IN of)
                          (NP (JJ individual) (NNS rats)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Statistical) (NN significance))
    (VP (VBD was)
      (VP (VBN accepted)
        (PP (IN at)
          (NP (NNP P) (NNP ≤) (CD 0.05)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Total) (NN T) (NNS cells)
          (CC and)
          (NNP CD4) (NNP +) (NNP T) (NNS cells))
        (PP (IN from)
          (NP
            (NP (NNS spleens))
            (PP (IN of)
              (NP (JJ individual) (NNS rats))))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NN day) (CD 13))
          (PP (IN of)
            (NP (NNP AA))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN in)
          (ADJP (NN vitro)
            (PP (IN with)
              (NP (NNP ConA)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The)
        (ADJP (IN in) (NN vitro))
        (NN proliferation) (NNS rates))
      (PP (IN of)
        (NP
          (NP (JJ total) (NNP T) (NNS cells))
          (PP (IN from)
            (NP
              (NP
                (ADJP (JJ OX35) (: -)
                  (CC and)
                  (JJ W3/25-treated))
                (NNS animals))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP
                      (NP (JJ polyspecific) (NN stimulation))
                      (PP (IN with)
                        (NP (NNP ConA))))))))))))
    (VP (VBD were)
      (ADJP (JJR higher))
      (PP (IN than)
        (NP
          (NP (DT those))
          (PP (IN of)
            (NP (JJ PBS-treated) (NNS rats)))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP
            (NP (NNP T) (NNS cells))
            (PP (IN of)
              (NP (DT the) (NN RIB5/2-treated) (NNS rats))))
          (VP (VBD showed)
            (S
              (NP (NN proliferation) (NNS rates))
              (ADJP (JJ similar)
                (PP (TO to)
                  (NP
                    (NP (DT those))
                    (PP (IN of)
                      (NP (NNP T) (NNS cells)))))))
            (PP (IN from)
              (NP
                (NP (JJ PBS-treated) (NNS animals))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Supplementary)
                    (QP (CD Fig.) (CD 2)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP ConA) (NNP stimulation))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
    (VP (VBD resulted)
      (PP (IN in)
        (NP
          (ADJP (RB generally) (JJR lower))
          (NN proliferation) (NNS rates)))
      (PP (IN than)
        (NP
          (NP (DT those))
          (PP (IN of)
            (NP (JJ total) (NNP T) (NNS cells)))))
      (PP (IN in)
        (NP (JJ PBS-treated) (NNS rats))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS values))
      (PP (IN of)
        (NP
          (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
          (PP (IN from)
            (NP (JJ individual) (, ,) (JJ anti-CD4-treated) (NNS animals))))))
    (VP (VBD were)
      (ADVP (RB always))
      (ADJP (JJR higher))
      (PP (IN than)
        (NP
          (NP (DT those))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ PBS-treated) (NN control) (NN group))
              (PRN (-LRB- -LRB-)
                (NP (NNP Supplementary) (NNP Fig.) (NNP 3a))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (EX There))
      (VP (VBD was)
        (NP
          (NP (DT a)
            (ADJP (RB highly) (JJ significant))
            (JJ negative) (NN correlation))
          (PP (IN between)
            (NP
              (NP (DT the) (NN degree))
              (PP (IN of)
                (NP
                  (NP
                    (NP (DT the) (JJ ConA-induced) (NN proliferation))
                    (PP (IN of)
                      (NP (NNP CD4) (NNP +) (NNP spleen) (NNP T) (NNS cells))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN severity))
                    (PP (IN of)
                      (NP (DT the) (NN arthritis) (NN score)))))))))))
    (, ,)
    (VP (VBZ i.e.)
      (NP (DT the) (JJR lower)))
    (NP
      (NP (DT the) (NN arthritis) (NN score))
      (, ,)
      (NP
        (NP (DT the) (JJR higher))
        (NP
          (NP (DT the) (NN proliferation) (NN rate))
          (PRN (-LRB- -LRB-)
            (NP (NNP Supplementary) (NNP Fig.) (NNP 3b))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT these) (NNS experiments)))
    (, ,)
    (NP
      (NP
        (NP (DT the) (JJ inhibitory) (NN potency))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ anti-CD4) (NNS mAbs))
            (PP (IN on)
              (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture))))))
      (, ,)
      (NP
        (NP (DT an) (NN equivalent))
        (PP (IN of)
          (NP (DT a) (NN transplant) (NN rejection))))
      (, ,))
    (VP (VBD was)
      (VP (VBN investigated)
        (PP (IN as)
          (NP
            (NP (DT a) (NN model))
            (PP (IN for)
              (NP (JJ MHC-dependent) (JJ T-cell) (NN activation)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ anti-CD4) (NNS mAbs))
    (ADVP (RB moderately))
    (VP (VBD inhibited)
      (NP
        (NP (DT the) (NN proliferation))
        (PP (IN of)
          (NP (JJ total) (JJ spleen) (NNP T) (NNS cells))))
      (, ,)
      (PP (VBG depending)
        (PP (IN on)
          (NP
            (NP (DT the) (NN stimulator) (NN cell) (NN concentration))
            (PRN (-LRB- -LRB-)
              (NP (NNP Supplementary) (NNP Fig.) (NNP 4a))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2))
    (VP (VBD led)
      (PP (TO to)
        (NP (JJ significant) (NN inhibition)))
      (PP (IN at)
        (NP
          (NP
            (NP (DT all) (NNS concentrations))
            (PP (IN of)
              (NP (NN mAb))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 1) (, ,) (CD 5) (, ,)
                (CC and)
                (CD 10))
              (SBAR
                (S
                  (NP
                    (NP (NN μg))
                    (PRN (: /)
                      (NP
                        (NP (NN ml))
                        (: ;)
                        (NP (RB only) (CD 1) (NN μg)))
                      (: /)))
                  (ADVP (RB ml))
                  (VP (VBZ is)
                    (VP (VBN shown)
                      (PP (IN in)
                        (NP (NNP Supplementary) (NNP Fig.) (NNPS 4a))))))))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (NNP DC))
            (, ,)
            (SBAR (IN whereas)
              (S
                (NP (DT the) (JJ other) (CD two) (JJ anti-CD4) (NNS mAbs))
                (ADVP (RB significantly))
                (VP (VBD inhibited)
                  (NP (DT the) (NN proliferation))
                  (ADVP (RB only))
                  (PP (IN in)
                    (NP (DT some) (NNS cases))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP RIB5/2))
    (VP (VBD inhibited)
      (NP (DT the) (NN proliferation))
      (PP (TO to)
        (NP
          (NP (DT a)
            (ADJP (RB statistically) (JJ significant))
            (NN degree))
          (PP (IN at)
            (NP (CD 1) (NN μg)))))
      (PRN (: /)
        (S
          (NP
            (NP (NN ml))
            (CC and)
            (NP (CD 2) (NNP ×) (CD 104) (NNP DC/well)))
          (ADJP (RBR more) (RB strongly))))
      (PP (IN than)
        (NP (DT both) (NNP W3/25)
          (CC and)
          (NNP OX35))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP (DT these) (NN differential) (NNS results))
      (PRN (-LRB- -LRB-)
        (NP (NNP inversely))
        (-RRB- -RRB-)))
    (VP (VBP match)
      (NP
        (NP (DT the) (NN differential) (JJ clinical) (NN efficacy))
        (VP (VBN seen)
          (PP (IN with)
            (NP (DT the) (CD three) (NNS mAbs))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN possibility))
      (SBAR (IN that)
        (S
          (NP (NNP CD8) (NNP +) (NNP T) (NNS cells))
          (VP (MD would)
            (VP (VB mask)
              (NP
                (NP (DT the) (JJ inhibitory) (NN potency))
                (PP (IN of)
                  (NP (DT the) (JJ anti-CD4) (NNS mAbs))))
              (PP (IN on)
                (NP
                  (NP (DT the) (NN proliferation))
                  (PP (IN of)
                    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
              (PP (IN in)
                (NP (DT a) (JJ total) (JJ T-cell) (NN population))))))))
    (VP (VBD was)
      (VP (VBN excluded)
        (PP (IN by)
          (S
            (VP (VBG using)
              (NP (CD purified) (NNP CD4) (NNP +) (NNP T) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP They))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJR clearer) (NN inhibition))
        (PP (IN of)
          (NP (PRP$ their) (NN proliferation) (NNS rates))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP
            (QP (CD 50) (TO to) (CD 80))
            (NN %))
          (PP (IN in)
            (NP (NN comparison))))
        (PP (IN with)
          (NP (DT the) (NN isotype)))
        (-RRB- -RRB-))
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN used)
            (PP (IN as)
              (NP (NN responder) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN in)
      (NP
        (NP (NN contrast))
        (PP (TO to)
          (NP (DT the) (JJ total) (JJ T-cell) (NN population)))))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ inhibitory) (NN potency))
            (PP (IN among)
              (NP
                (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Supplementary) (NNP Fig.) (NNP 4b))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN In) (NN order)
      (S
        (VP (TO to)
          (VP (VB characterize)
            (NP
              (NP (DT the) (VBG depleting)
                (CC and)
                (VBG modulating) (NN capacity))
              (PP (IN of)
                (NP (DT the) (CD three) (NNS mAbs))))))))
    (, ,)
    (NP
      (NP (NNS FACS))
      (PP (IN of)
        (NP (JJ peripheral) (NN blood) (NN mononu-clear) (NNS cells))))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN on)
          (NP
            (NP (NNS days) (CD 8)
              (CC and)
              (CD 13))
            (PP (IN of)
              (NP
                (NP (NNP AA))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Supplementary) (NNP Table) (NNP 2A))
                  (, ,)
                  (NP (NNP B))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD Two) (JJ different) (JJ anti-CD4) (NNS mAbs))
      (PRN (-LRB- -LRB-)
        (S
          (NP (NNP W3/25)
            (CC and)
            (NNP OX35))
          (, ,)
          (NP (WDT which))
          (VP (VBP do) (RB not)
            (VP (VB compete)
              (PP (IN for)
                (NP (NNP CD4) (NNP binding))))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN employed)
        (S
          (VP (TO to)
            (VP (VB differentiate)
              (NP (NN coating))
              (PP (IN with)
                (NP (JJ therapeutic) (NN mAb)))
              (PP (IN from)
                (NP
                  (NP (NN depletion))
                  (PP (IN of)
                    (NP (NNP CD4) (NNP +) (NNP T) (NNP cells/CD4-modulation))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN treatment))
        (PP (IN with)
          (NP (NNP W3/25)))))
    (, ,)
    (NP
      (NP
        (NP (DT the) (NN percentage) (NN and/or) (NN MFI))
        (PRN (-LRB- -LRB-)
          (NP (JJ mean) (NN fluorescence) (NN intensity))
          (-RRB- -RRB-)))
      (PP (IN of)
        (NP
          (NP (CD CD3) (JJ +) (NNS cells))
          (PP (IN in)
            (NP
              (NP (DT the) (JJ peripheral) (NN blood))
              (PP (IN on)
                (NP (NNS days) (CD 8)
                  (CC and)
                  (CD 13))))))))
    (VP (VBD was)
      (ADJP
        (ADJP (RB numerically) (JJR lower))
        (PP (IN than)
          (PP (IN in)
            (NP (DT the) (JJ PBS-treated) (NN control) (NN group)))))
      (, ,)
      (S
        (VP (VBG resulting)
          (PP (IN in)
            (NP (DT a)
              (ADJP (RB significantly) (JJR lower))
              (NN MFI)))
          (PP (IN on)
            (NP (NN day) (CD 13)))
          (PRN (-LRB- -LRB-)
            (FRAG
              (NP (NN note))
              (: :)
              (S
                (NP
                  (NP (DT the) (NN fact))
                  (SBAR (IN that)
                    (S
                      (PP (IN on)
                        (NP (NN day)))
                      (NP
                        (NP (CD 8) (RB only) (CD two) (NNS animals))
                        (PP (IN of)
                          (NP (DT the) (NN W3/25-treated) (NN group))))
                      (VP (VBD were)
                        (VP (VBN investigated)
                          (S
                            (ADJP (JJ likely))))))))
                (VP (VBD prevented)
                  (NP (JJ statistical) (NN significance)))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT a) (NN decrease))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNS cells))))
    (VP (VBD was)
      (VP (VBN observed)
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (DT the) (NNS cells))
            (VP (VBD were)
              (VP (VBN stained)
                (PP (IN with)
                  (NP (NNP OX35)))
                (PRN (-LRB- -LRB-)
                  (ADJP
                    (ADJP (RBR more) (JJ prominent))
                    (PP (IN on)
                      (NP
                        (NP (NN day) (CD 13))
                        (: ;)
                        (S
                          (VP (VB see)
                            (NP (NNP Supplementary) (NNP Table) (CD 2B)))))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP
          (NP (JJ ex) (NN vivo))
          (VP (VBG staining)
            (PP (IN with)
              (NP (NNP W3/25)))))
        (: --)
        (NP
          (NP (DT the) (NN mAb))
          (VP
            (ADVP (RB also))
            (VBN used)
            (PP (IN for)
              (NP (NN treatment)))))
        (: --)
        (NP
          (NP
            (NP
              (QP (RB only) (CD 7))
              (NN %))
            (PRN (-LRB- -LRB-)
              (NP (NN day) (CD 8))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (NP
              (NP (CD 28) (NN %))
              (PRN (-LRB- -LRB-)
                (NP (NN day) (CD 13))
                (-RRB- -RRB-)))
            (PP (IN of)
              (NP (DT the) (JJ peripheral) (NN blood)))))))
    (NP (NN mononuclear) (NNS cells))
    (VP (VBD were)
      (NP (NNP CD4) (NNP +)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT This) (NN fact))
      (, ,)
      (CC and)
      (NP
        (NP (DT the) (JJ positive) (NN staining))
        (PP (IN with)
          (NP
            (NP (DT an) (JJ anti-mouse) (NN IgG))
            (PP (IN on)
              (NP
                (NP (NNS days) (CD 8)
                  (CC and)
                  (CD 13))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP
                      (NP (CD 18) (NN %))
                      (CC and)
                      (NP (CD 9) (NN %)))
                    (, ,)
                    (ADVP (RB respectively)))
                  (-RRB- -RRB-)))))))
      (, ,))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ therapeutic) (JJ anti-CD4) (NN mAb))
          (VP (VBD was)
            (ADJP (JJ present)
              (PP (IN on)
                (NP
                  (NP (DT the) (NNS cells))
                  (NP
                    (QP (RB as) (JJ long) (IN as) (CD 7))
                    (NNS days)))))
            (PP (IN after)
              (NP
                (NP (DT the) (JJ last) (NN injection))
                (PP (IN of)
                  (NP (DT the) (NN mAb)))))))))
    (. .)))

(ROOT
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN treatment))
          (PP (IN with)
            (NP (NNP W3/25)))))
      (, ,)
      (NP
        (NP (DT the) (NN percentage))
        (PP (IN of)
          (NP (NNP CD8) (NNP +) (NNS cells))))
      (VP (VBD did) (RB not)
        (VP (VB show)
          (NP (DT any) (JJ significant) (NNS changes))
          (PP (IN on)
            (NP (NNS days) (CD 8)
              (CC or)
              (CD 13))))))
    (: ;)
    (S
      (ADVP (RB however))
      (, ,)
      (NP
        (NP (DT the) (NNP MFI))
        (PP (IN for)
          (NP
            (NP (NNP CD8))
            (PP (IN on)
              (NP (NN day) (CD 13))))))
      (VP (VBD was)
        (ADVP (RB significantly))
        (VP (VBN decreased)
          (PRN (-LRB- -LRB-)
            (S
              (VP (VB see)
                (NP (NNP Supplementary) (NNP Table) (CD 2B))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP (DT the) (JJ anti-CD4) (NN mAb) (NN W3/25))
    (VP (VBN induced)
      (NP
        (NP (RB only) (JJ weak) (NN depletion))
        (PP (IN of)
          (NP (NNP CD4) (NNP +) (NNS cells))))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBD indicated)
            (PP (IN by)
              (NP
                (NP
                  (ADJP (JJ unchanged))
                  (NNS percentages))
                (PP (IN of)
                  (NP (NNP CD8) (NNP +) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP
          (NP (NN modulation))
          (PP (IN of)
            (NP
              (NP (DT the) (NN CD4)
                (CC and)
                (NN co-modulation))
              (PP (IN of)
                (NP (DT the) (NNP CD3) (NN surface) (NNS molecules))))))
        (CC and)
        (NP
          (NP (JJ indirect) (NN modulation))
          (PP (IN of)
            (NP (DT the) (NNP CD8) (NN molecule))))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VB see)
              (NP (NNP Supplementary) (NNP Table) (CD 2B))))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ anti-CD4) (NN mAb) (NN W3/25))
    (ADVP (RB therefore))
    (VP (VBD represented)
      (NP (DT a)
        (ADJP
          (ADJP (RB weakly) (JJ depleting))
          (, ,)
          (CC but)
          (ADJP (JJ modulating)))
        (NN antibody)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (JJ peripheral) (NN blood))
        (PP (IN of)
          (NP (NN OX35-treated) (NNS rats)))))
    (, ,)
    (NP
      (NP (DT the) (NN percentage))
      (PP (IN of)
        (NP (NNP CD3) (NNP +) (NNS cells))))
    (VP (VBD was)
      (ADJP
        (ADJP (RB significantly) (JJR lower))
        (PP (IN than)
          (PP (IN in)
            (NP (JJ PBS-treated) (NNS animals)))))
      (PRN (-LRB- -LRB-)
        (S
          (VP (VB see)
            (NP
              (NP (NNP Supplementary) (NNP Table) (NNP 2A))
              (, ,)
              (NP (NNP B)))))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN percentage))
      (PP (IN of)
        (NP
          (NP (CD CD4) (JJ +) (NNS cells))
          (PP (IN in)
            (NP (DT the) (NN OX35-treated) (NN group))))))
    (VP (VBD was)
      (ADVP (RB also))
      (ADJP (RB significantly) (JJR lower))
      (PP
        (PP (IN than)
          (NP
            (NP (DT that))
            (PP (IN of)
              (NP (DT the) (NNP PBS) (NN control)))))
        (, ,)
        (CC both)
        (PP (IN upon)
          (S
            (VP
              (VP (VBG staining)
                (PP (IN with)
                  (NP (NNP W3/25)
                    (CC and)
                    (NNP OX35))))
              (PRN (-LRB- -LRB-)
                (S
                  (VP (VB see)
                    (NP
                      (NP (NNP Supplementary) (NNP Table) (NNP 2A))
                      (, ,)
                      (NP (NNP B)))))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN therapeutically))
    (VP (VBD applied)
      (SBAR
        (S
          (NP (NNP OX35))
          (VP (VBD was)
            (ADJP
              (ADVP (RB no) (RBR longer))
              (JJ present)
              (PP (IN on)
                (NP (DT the) (NNS cells))))
            (PP (IN at)
              (NP (DT this) (NN stage)))
            (, ,)
            (SBAR (IN as)
              (S
                (VP (VBD demonstrated)
                  (PP (IN by)
                    (NP (JJ negative) (NN staining)))
                  (PP (IN for)
                    (NP (NN mouse) (NN IgG))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN percentage))
      (PP (IN of)
        (NP
          (NP (CD CD8) (JJ +) (NNS cells))
          (PP (IN of)
            (NP (NN OX35-treated) (NNS rats))))))
    (VP (VBD was)
      (VP
        (ADVP (CC either)
          (RB significantly)
          (CC or)
          (RB numerically))
        (VBN increased)
        (PP (VBN compared)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ PBS-treated) (NN control))
              (PP (IN on)
                (NP (NN day)
                  (QP (CD 8)
                    (CC or)
                    (CD 13)))))))
        (, ,)
        (ADVP (RB respectively))
        (, ,)
        (SBAR (IN whereas)
          (S
            (NP
              (NP (DT the) (NNP MFI))
              (PP (IN of)
                (NP (DT the) (NNP CD8) (NN molecule))))
            (VP (VBD was)
              (ADVP (RB significantly))
              (VP (VBN decreased)
                (PP (IN on)
                  (NP (DT both) (NNS days)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN comparison))
        (PP (IN with)
          (NP (NNP W3/25)))))
    (, ,)
    (NP (DT the) (NN mAb) (NN OX35))
    (VP (VBN induced)
      (NP
        (NP (DT a) (JJR clearer) (NN depletion))
        (PP (IN of)
          (NP
            (NP (CD CD4) (JJ +) (NNS cells))
            (PP (IN of)
              (NP (DT the) (JJ peripheral) (NN blood))))))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBD indicated)
            (PP (IN by)
              (NP (DT a) (JJ significant) (NN increase)))
            (PP (IN in)
              (NP
                (NP (DT the) (NN percentage))
                (PP (IN of)
                  (NP (NNP CD8) (NNP +) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT the) (NN mAb) (NN OX35))
    (VP (VBN induced)
      (S
        (ADJP (JJ CD4-modulation)
          (CC and)
          (JJ CD3-co-modulation)))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBN shown)
            (PP (IN by)
              (NP
                (NP
                  (NP (DT a) (JJ profound) (NN decrease))
                  (PP (IN of)
                    (NP (NNP CD4) (NNP +) (NNS cells))))
                (CC and)
                (NP
                  (NP (DT a) (NN decrease))
                  (PP (IN of)
                    (NP (DT the) (NNP MFI))))))
            (PP (IN for)
              (NP (NNP CD4)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP (NNP OX35))
    (VP (VBD represented)
      (NP (DT a)
        (ADJP (JJ depleting)
          (CC and)
          (JJ modulating))
        (NN antibody)))
    (. .)))

(ROOT
  (S
    (NP (NNP RIB5/2))
    (VP
      (ADVP (RB also))
      (VBZ induced)
      (NP
        (NP (DT a) (JJ significant) (NN reduction))
        (PP (IN of)
          (NP
            (NP (CD CD3) (JJ +) (NNS cells))
            (PP (IN in)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (DT the) (NNP PBS) (NN group))))))))
      (PRN (-LRB- -LRB-)
        (S
          (VP (VB see)
            (NP
              (NP (NNP Supplementary) (NNP Table) (NNP 2A))
              (, ,)
              (NP (NNP B)))))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN percentage))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNS cells))))
    (VP (VBD was)
      (ADVP (RB also))
      (VP
        (ADVP (RB significantly))
        (VBN decreased)
        (PP (IN on)
          (NP (NNS days) (CD 8)
            (CC and)
            (CD 13)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN of)
          (NP
            (NP (CD CD8) (JJ +) (NNS cells))
            (PP (IN in)
              (NP (DT the) (NN periphery)))
            (PP (IN of)
              (NP (NN RIB5/2-treated) (NNS rats)))
            (PP (IN in)
              (NP (NN comparison)))
            (PP (IN with)
              (NP (DT the) (JJ PBS-treated) (NN control)))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB see)
                  (NP
                    (NP (NNP Supplementary) (NNP Table) (NNP 2A))
                    (, ,)
                    (NP (NNP B)))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Similarly))
    (PP (TO to)
      (NP
        (NP (DT the) (NNS findings))
        (PP (IN for)
          (NP (NNP mAb) (NNP OX35)))))
    (, ,)
    (S
      (NP (NNP mAb) (NNP RIB5/2))
      (VP (VBN induced)
        (NP (JJ T-cell) (NN depletion)
          (CC and)
          (NN CD4) (NNS modulation))))
    (: ;)
    (S
      (ADVP (RB however))
      (, ,)
      (NP
        (NP (DT the) (NN degree))
        (PP (IN of)
          (NP (JJ peripheral) (JJ T-cell) (NN depletion))))
      (VP (VBD was)
        (ADVP (JJR stronger) (IN than))
        (PP (IN in)
          (NP
            (NP (DT the) (NN case))
            (PP (IN of)
              (NP (NNP OX35)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (SBAR
      (SBAR (IN since)
        (S
          (NP
            (NP (DT both) (VBG ameliorating)
              (CC and)
              (VBG accelerating) (NNS mAbs))
            (PRN (-LRB- -LRB-)
              (NP (NNP OX35)
                (CC and)
                (NNP RIB5/2))
              (-RRB- -RRB-)))
          (VP (VBD depleted)
            (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
            (PP (IN from)
              (NP (JJ peripheral) (NN blood))))))
      (, ,)
      (CC and)
      (SBAR (IN since)
        (S
          (NP (DT all) (CD three) (NNS mAbs))
          (VP (VBD were)
            (VP (VBG modulating))))))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ apparent) (NN match))
        (PP (IN of)
          (NP
            (NP (DT these) (NNS parameters))
            (PP (IN with)
              (NP (DT the) (JJ clinical) (NN efficacy)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Intracellular) (NN staining))
      (PP (IN of)
        (NP
          (NP (NNS cells))
          (VP (VBN preincubated)
            (PP (IN with)
              (NP
                (NP (JJ anti-CD4) (NNS mAbs))
                (CC or)
                (NP (JJ isotype) (NNS controls))))))))
    (VP (VBD showed)
      (NP (DT a) (JJ uniformly) (JJ high) (NN expression))
      (PP (IN for)
        (NP
          (NP (NNP IFN-γ))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Supplementary) (NNP Fig.))
              (NP
                (NP
                  (NP (NNS 5a))
                  (, ,)
                  (NP (SYM b)))
                (: ;)
                (NP
                  (NP
                    (QP (IN between) (CD 80) (NN %)
                      (CC and)
                      (CD 100) (NN %)))
                  (NP (JJ positive) (NNS cells)))
                (: ;)
                (NP
                  (NP (NNP MFI))
                  (NP
                    (QP (RB approximately) (CD 30))))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBD were)
      (NP
        (NP (DT no) (NNS differences))
        (PP (IN between)
          (NP (DT the) (JJ anti-CD4) (JJ mAb-treated)
            (CC or)
            (JJ isotype-treated) (NNS cultures))))
      (PP (IN for)
        (NP
          (NP (DT the) (NN concentration))
          (PP (IN of)
            (NP
              (NP (NNP IFN-γ))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN supernatant))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Supplementary) (NNP Fig.) (NNP 5c))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (JJ anti-CD4) (NN mAb) (NN W3/25))
      (VP (VBN induced)
        (NP
          (NP (DT a)
            (ADJP (RB significantly) (JJR higher))
            (NN percentage))
          (PP (IN of)
            (NP (NN IL-4-positive) (NNS cells))))
        (PP (IN at)
          (NP
            (NP (CD 24)
              (CC and)
              (CD 48) (NNS hours))
            (SBAR (IN than)
              (SINV (VBD did)
                (NP
                  (NP (DT the) (JJ isotype) (NN control))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Supplementary) (NNP Fig.) (NNP 5d))
                    (-RRB- -RRB-)))))))))
    (: ;)
    (S
      (NP (DT the) (NNP MFI))
      (VP (VBD was)
        (ADVP (RB also))
        (ADJP
          (ADJP (RB significantly) (JJR higher))
          (PP (IN in)
            (NP (NN comparison))))
        (PP (IN with)
          (NP
            (NP (NNP OX35)
              (CC and)
              (NNP RIB5/2))
            (PRN (-LRB- -LRB-)
              (NP (NNP Supplementary) (NNP Fig.) (NNP 5e))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (EX there))
    (VP (VBD were)
      (NP
        (NP (DT no) (JJ significant) (NNS differences))
        (PP (IN of)
          (NP
            (NP (DT the) (NN IL-4) (NN concentration))
            (PP (IN in)
              (NP
                (NP (DT the) (NN supernatant))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNS cultures))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Supplementary) (NNP Fig.) (NNP 5f))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN observation))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ attributable)
          (PP (TO to)
            (NP
              (NP (DT a) (JJ delayed) (NN secretion))
              (PP (IN of)
                (NP
                  (NP (NN IL-4)
                    (CC or)
                    (NN consumption))
                  (PP (IN of)
                    (NP (DT the) (NN cytokine))))))))
        (PP (IN during)
          (NP (NN culture)))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP (CD 24) (NN h)))
    (, ,)
    (NP
      (NP (DT a) (JJ numerical) (NN increase))
      (PP (IN of)
        (NP
          (NP (DT the) (NN percentage))
          (PP (IN of)
            (NP (NN IL-10-positive) (NNS cells))))))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN detected)
          (PP (IN after)
            (NP (NN preincubation)))
          (PP (IN with)
            (NP
              (NP (DT the) (VBG ameliorating) (NN mAb) (NN W3/25))
              (CC and)
              (NP (DT the) (VBG accelerating) (NN mAb) (NN RIB5/2))))
          (, ,)
          (SBAR (IN whereas)
            (S
              (NP
                (NP (DT the) (JJ other) (NN ameliorating) (NN mAb))
                (, ,)
                (NP (NNP OX35))
                (, ,))
              (VP (VBN induced)
                (NP
                  (NP (DT a) (JJ significant) (NN increase))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Supplementary) (NNP Fig.) (NNP 5g))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN increase))
    (VP (VBD was)
      (ADVP (RB no) (RB longer))
      (VP (VBN observed)
        (PP (IN at)
          (NP
            (NP (CD 48) (NN h))
            (PRN (-LRB- -LRB-)
              (NP (NNP Supplementary) (NNP Fig.) (NNP 5g))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (NNP MFI))
      (PP (IN for)
        (NP (NN IL-10))))
    (VP (VBD was)
      (VP (VBN increased)
        (NP
          (NP (DT both) (CD 24) (NN h))
          (CC and)
          (NP (CD 48) (NN h)))
        (PP (IN after)
          (NP (NN pretreatment)))
        (PP (IN with)
          (NP (JJ anti-CD4) (NNS mAbs)))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP (CD 24) (NN h)))
    (, ,)
    (NP
      (NP (RB only) (DT the) (NN increase))
      (VP (VBN induced)
        (PP (IN by)
          (NP (DT the) (NN mAb) (NN OX35)))))
    (VP (VBD was)
      (UCP
        (ADJP (JJ significant))
        (, ,)
        (CC but)
        (PP (IN at)
          (NP
            (NP (CD 48) (NN h))
            (VP
              (ADVP (RB all)
                (NP (CD three) (NNS mAbs)))
              (VBN induced)
              (NP
                (NP (DT a) (JJ significant) (NN increase))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNP MFI))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Supplementary) (NNP Fig.) (NNP 5h))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Preincubation))
      (PP (IN with)
        (NP
          (NP (DT all) (JJ anti-CD4) (NNS mAbs))
          (VP (VBN induced)
            (NP
              (NP (DT a)
                (ADJP (RB significantly) (JJR higher))
                (NN secretion))
              (PP (IN of)
                (NP (NN IL-10))))
            (PP (IN than))))))
    (VP (VBD did)
      (NP (DT the) (JJ isotype) (NN control))
      (, ,)
      (PP
        (CONJP (RB not) (JJ only))
        (PP (IN after)
          (NP (CD 24) (NN h)))
        (, ,)
        (CONJP (CC but)
          (RB also))
        (PP (IN after)
          (NP
            (NP (CD 48) (NNS hours))
            (PRN (-LRB- -LRB-)
              (S
                (NP (DT the) (JJ latter) (NN increase))
                (VP (VBD did) (RB not)
                  (VP (VB reach)
                    (NP (JJ statistical) (NN significance))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN case))
                        (PP (IN of)
                          (NP (NNP OX35))))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN None))
      (PP (IN of)
        (NP (DT the) (NNS parameters))))
    (, ,)
    (ADVP (RB however))
    (, ,)
    (VP (VBD showed)
      (NP (JJ significant) (NNS differences))
      (PP (IN among)
        (NP
          (NP (DT the) (CD three) (JJ different) (JJ anti-CD4) (NNS mAbs))
          (PRN (-LRB- -LRB-)
            (NP (NNP Supplementary) (NNP Fig.) (NNP 5i))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN use))
        (PP (IN of)
          (S
            (VP (VBG nondepleting)
              (NP (JJ anti-CD4) (NNS mAbs))
              (PP (IN for)
                (NP
                  (NP (NN treatment))
                  (PP (IN of)
                    (NP (JJ human) (JJ rheumatoid) (NN arthritis)))))))))
      (VP (VBZ is)
        (VP (VBG being)
          (VP (VBN discussed)
            (PP (IN at)
              (ADJP (JJ present)))))))
    (: ;)
    (S
      (NP (JJ such) (NN treatment))
      (VP (MD would)
        (VP (VB be)
          (VP (VBN intended)
            (S
              (VP
                (VP (TO to)
                  (VP
                    (VP (VB influence)
                      (NP
                        (NP (DT the) (NN reactivity))
                        (PP (IN of)
                          (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))))
                    (, ,)
                    (CONJP (RB rather) (IN than))
                    (VP (VB remove)
                      (NP (PRP them))
                      (ADVP (RB completely)))))
                (PRN (-LRB- -LRB-)
                  (SBAR
                    (ADVP (RB particularly))
                    (IN since)
                    (S
                      (NP (NN depletion))
                      (VP (MD may)
                        (VP (VB induce)
                          (NP (JJ transient) (NN immunodeficiency))))))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN vivo)))
    (, ,)
    (NP
      (NP (DT the) (VBG depleting)
        (CC and)
        (VBG modulating) (NNS capacities))
      (PP (IN of)
        (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))))
    (VP (VBD were)
      (ADJP (JJ different)))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (NP (NNP W3/25))
        (VP (VBD was)
          (NP (DT a)
            (ADJP
              (ADJP (RB weakly) (JJ depleting))
              (, ,)
              (CC but)
              (ADJP (RB clearly) (JJ modulating))
              (, ,))
            (NN mAb)))))
    (, ,)
    (S
      (NP (NNP RIB5/2)
        (CC and)
        (NNP OX35))
      (VP (VBD were)
        (ADVP (RB moderately)
          (CC or)
          (RB strongly))
        (VP (VBG depleting)
          (CC and)
          (VBG modulating)
          (NP (NNS mAbs))))
      (, ,)
      (ADVP (RB respectively)))
    (: ;)
    (S
      (NP (DT this) (NN pattern))
      (VP (VBD did) (RB not)
        (VP (VB match)
          (NP
            (NP (DT the) (NN treatment) (NNS effects))
            (PP (IN of)
              (NP (DT the) (CD three) (NNS mAbs)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (NNP CD4) (NNP +) (NNP T-cell) (NN depletion))
    (VP (VBD was)
      (VP (VBN assessed)
        (ADVP (RB only))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ peripheral) (NN blood))
            (, ,)
            (NP
              (NP (DT the) (NN compartment))
              (ADJP (RBS most) (RB easily) (JJ accessible))
              (ADVP (RB also))
              (PP (IN in)
                (NP (NNS humans))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (NP
          (NP (NN depletion/modulation))
          (PP (IN in)
            (NP (JJ peripheral) (NN blood))))
        (VP (MD may)
          (VP (VB differ)
            (PP (IN from)
              (NP
                (NP (DT that))
                (PP (IN in)
                  (NP
                    (NP (JJ other) (NNS compartments))
                    (PRN (-LRB- -LRB-)
                      (NP (JJ e.g.) (JJ lymphoid) (NNS organs))
                      (-RRB- -RRB-))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN use))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS terms))
          (ADJP (`` `) (JJ depleting) ('' ')
            (CC or)
            (`` `) (JJ nondepleting) ('' ')))))
    (VP (VBZ has)
      (S
        (VP (TO to)
          (VP (VB be)
            (VP (VBN restricted)
              (PP (TO to)
                (NP (DT the) (NN blood))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN case))
        (PP (IN of)
          (NP (DT the) (NNS mAbs) (NNP W3/25)
            (CC and)
            (NNP OX35)))))
    (, ,)
    (ADVP (RB however))
    (, ,)
    (NP
      (NP (NNS studies))
      (PP (IN with)
        (NP (JJ marked) (, ,) (JJ antibody-coated) (NNS cells))))
    (VP (VBP indicate)
      (NP
        (NP (DT a) (NN redistribution))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS cells))
            (PP (IN from)
              (NP (JJ lymphoid) (NNS organs))))))
      (PP (TO to)
        (NP
          (NP (DT the) (NN liver))
          (, ,)
          (PP
            (ADVP (RB possibly))
            (VBG including)
            (NP
              (NP (NNS phagocytosis)
                (CC and)
                (NN depletion))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ opsonized) (`` `) (NNS cells) ('' '))
                  (PP (IN by)
                    (NP
                      (NP (NN liver) (NNS macrophages))
                      (PRN (-LRB- -LRB-)
                        (NP (JJ unpublished) (NNS observations))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Contrasting)
        (NP
          (NP (JJR earlier) (NNS findings))
          (PP (VBG concerning)
            (NP
              (NP (DT the) (VBG depleting) (NN capacity))
              (PP (IN of)
                (NP (DT the) (NNP mAb) (NNP RIB5/2) (NNP -LSB-) (NNP S7))))))))
    (, ,)
    (NP (NNP S8) (NNP -RSB-))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ attributable)
          (PP (TO to)
            (NP
              (NP
                (NP (JJ different) (NN time) (NNS points))
                (PP (IN of)
                  (NP (NN investigation))))
              (, ,)
              (NP
                (NP (JJ different) (NNS amounts))
                (PP (IN of)
                  (NP (JJ injected) (NN mAb))))
              (CC or)
              (NP
                (NP (NN number))
                (PP (IN of)
                  (NP
                    (NP (JJ therapeutic) (NNS injections))
                    (, ,)
                    (CC and)
                    (NP (JJ different) (JJ experimental) (NNS models))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (JJ personal) (NN communication))
                        (, ,)
                        (NP (NNP Dr) (NNP M) (NNP Lehmann)))
                      (, ,)
                      (NP
                        (NP (NNP University))
                        (PP (IN of)
                          (NP (NNP Rostock))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Differential) (NNS effects))
      (PP (IN of)
        (NP
          (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))
          (PP (IN on)
            (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture))))))
    (VP (VBD were)
      (VP (VBN noted)
        (PP
          (PP (RB only)
            (ADVP (RB occasionally)))
          (, ,) (RB especially)
          (PP (IN with)
            (NP (JJ total) (NNP T) (NNS cells))))
        (PP (IN as)
          (NP (NNS responders)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2))
    (VP (VBD was)
      (ADVP (RB again))
      (ADJP (RBR more) (JJ effective)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN observation))
      (PP (IN of)
        (NP (NN differential) (NNS effects))))
    (VP
      (VP
        (PP (RB only)
          (PP (IN with)
            (NP (JJ total) (NNP T) (NNS cells)))
          (, ,)
          (CONJP (CC but)
            (RB not))
          (PP (IN in)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))
        (, ,)
        (VP (VBZ indicates)
          (NP
            (NP (DT a) (NN differential) (NN contribution))
            (PP (IN of)
              (NP (DT the) (NNP CD4) (NNP +)
                (CC and)
                (NNP CD8) (NNP +) (NNP T-cell) (NN subpopulation)))))
        (CC and)
        (VP (VBZ suggests)
          (SBAR (IN that)
            (S
              (NP
                (NP (NNS interactions))
                (PP (IN between)
                  (NP (NNP CD4) (NNP +)
                    (CC and)
                    (NNP CD8) (NNP +) (NNP T) (NNS cells))))
              (VP (VBD -LSB-)
                (SBAR
                  (S
                    (NP (NNP S9) (NNP -RSB-))
                    (VP (VBP are)
                      (ADJP (JJ critical)
                        (PP (IN for)
                          (NP (JJ T-cell) (NN activation))))))))))))
      (CC and)
      (VP
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (JJ anti-CD4) (NNS mAbs))))
        (PP (IN on)
          (NP (DT this) (NN process)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (S
          (NP (JJ IFN-γ) (NN secretion))
          (VP (VBD was)
            (ADJP (RB completely) (JJ unaffected))
            (PP (IN by)
              (NP (JJ anti-CD4) (NN preincubation)))))
        (CC and)
        (S
          (NP (NN IL-4))
          (VP (VBD was)
            (ADVP (RB only))
            (VP (VBN increased)
              (PP (IN by)
                (NP
                  (NP (DT the) (NN mAb) (NN W3/25))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (RB as) (RB previously) (JJ reported))
                      (: ;)
                      (NP (NNP -LSB-) (NNP S10) (NNP -RSB-)))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (NN IL-10) (NN secretion))
    (VP (VBD was)
      (ADJP (RB strikingly) (JJ induced))
      (PP (IN by)
        (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))))
    (. .)))

(ROOT
  (S
    (PP
      (ADVP (IN At) (JJS least))
      (IN in)
      (NP
        (NP (DT the) (NN case))
        (PP (IN of)
          (NP (DT the) (VBG ameliorating) (NNS mAbs) (NNP W3/25)
            (CC and)
            (NNP OX35)))))
    (, ,)
    (NP (DT this) (NN effect))
    (VP
      (VP (VBZ is)
        (ADJP (JJ compatible)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ anti-inflammatory) (NN role))
              (PP (IN of)
                (NP (NN IL-10))))))
        (PP (IN in)
          (NP
            (NP (NNP arthritis) (NNP -LSB-) (NNP S11))
            (, ,)
            (NP (NNP S12) (NNP -RSB-)))))
      (CC and)
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN reported)
            (ADVP (RB also))
            (PP (IN after)
              (NP
                (NP (JJ anti-CD4) (NN therapy))
                (PP (IN in)
                  (NP (NNP transplantation) (NNP -LSB-) (NNP S13) (NNP -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN fact))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ total) (NN number))
            (PP (IN of)
              (NP
                (NP (NN IFN-γ-positive)
                  (CC and)
                  (NN IL-4))
                (: -)
                (NP
                  (NP (NNP /) (NNP IL-10-positive) (NNP T))
                  (NP (NNS cells))))))
          (VP (VBZ exceeds)
            (NP (CD 100) (NN %))))))
    (VP (VBZ indicates)
      (NP
        (NP (DT the) (NN presence))
        (PP (IN of)
          (NP
            (NP (CD TH0) (NNS cells))
            (PP (IN in)
              (NP (DT this) (JJ particular) (JJ experimental) (NN system)))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Abbreviations) (NNP AA) (NNP =) (NN rat) (NN adjuvant) (NN arthritis))
    (: ;)
    (NP
      (NP (NN AP-1))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN activator) (NN protein-1))))))
    (: ;)
    (NP
      (NP (NNP ConA))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN concanavalin) (NN A))))))
    (: ;)
    (NP
      (NP (NNP DC))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ dendritic) (NNS cells))))))
    (: ;)
    (NP
      (NP (NNP DTH))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ delayed-type) (NN hypersensitivity))))))
    (: ;)
    (NP
      (NP (NNP ELISA))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ enzyme-linked) (NN immunosorbent) (NN assay))))))
    (: ;)
    (NP
      (NP (NNS FACS))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN flowcytometry))))))
    (: ;)
    (NP
      (NP (NNP FCS))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ fetal) (NN calf) (NN serum))))))
    (: ;)
    (NP
      (NP (NNP FITC))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN fluorescein) (NN isothiocyanate))))))
    (: ;)
    (NP
      (NP (NNS HEPES))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NNP N))))))
    (: -)
    (NP
      (NP (-LRB- -LRB-) (NN 2-hydroxyethyl) (-RRB- -RRB-))
      (NP
        (NP
          (NP (NN piperazine-N) (POS '))
          (NN -))
        (PRN (-LRB- -LRB-)
          (NP (JJ 2-ethanesulfonic) (NN acid))
          (-RRB- -RRB-))))
    (: ;)
    (NP
      (NP (NNP IFN))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN interferon))))))
    (: ;)
    (NP
      (NP (NNP IL))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN interleukin))))))
    (: ;)
    (NP
      (NP (NNP KA) (NNP =))
      (ADJP (RB affinity) (JJ constant)))
    (: ;)
    (NP
      (NP (NNS kass))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN association) (NN rate) (NNS constant))))))
    (: ;)
    (NP
      (NP (NNS kdiss))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ dissociation) (NN rate) (NNS constant))))))
    (: ;)
    (NP
      (NP (NN mAb))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ monoclonal) (NN antibody))))))
    (: ;)
    (NP
      (NP (NNP MFI))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ mean) (NN fluorescence) (NN intensity))))))
    (: ;)
    (NP
      (NP (NNP MHC))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ major) (NN histocompatibility) (NN complex))))))
    (: ;)
    (NP
      (NP (JJ NF-AT) (JJ =) (JJ nuclear) (NN factor))
      (PP (IN of)
        (NP (NNP activated) (NNP T) (NNS cells))))
    (: ;)
    (NP
      (NP (NNP PBS))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ phosphate-buffered) (NN saline))))))
    (: ;)
    (NP
      (NP (NNP PE))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN phycoerythrin))))))
    (: ;)
    (NP
      (NP (NNP PMA))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ phorbol) (JJ myristoyl) (NN acetate))))))
    (: ;)
    (NP
      (NP (NNP PMSF))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ phenylmethylsulfonyl) (NN fluoride))))))
    (: ;)
    (NP
      (NP (NNP RPMI) (NNP =) (NNP Roswell) (NNP Park) (NNP Memorial) (NNP Institute))
      (NP (JJ -LSB-) (NN medium) (NNS -RSB-)))
    (: ;)
    (NP
      (NP (NNP SEM) (NNP =) (JJ standard) (NN error))
      (PP (IN of)
        (NP (DT the) (NN mean))))
    (: ;)
    (NP
      (NP (NNP Shc))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN src-homology-domain-containing-protein))))))
    (: ;)
    (NP
      (NP (NNP TNF))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN tumor) (NNS necrosis) (NN factor))))))
    (: ;)
    (NP
      (NP (NNP TCR))
      (SBAR
        (S
          (VP (SYM =)
            (NP (JJ T-cell) (NN receptor))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Figure)
        (CC and)
        (NNP Table))
      (VP (VBZ captions)
        (NP (NNP Figure) (CD 1))))
    (: :)
    (S
      (NP (NNP Arthritis))
      (VP (VBP score)
        (PP (IN after)
          (NP
            (NP (JJ preventive) (NN treatment))
            (PP (IN of)
              (NP
                (NP (NN rat) (NN adjuvant) (NN arthritis))
                (PRN (-LRB- -LRB-)
                  (NP (NNP AA))
                  (-RRB- -RRB-))))))
        (PP (IN with)
          (NP
            (NP (JJ various) (JJ anti-CD4) (NNS mAbs))
            (CC or)
            (NP
              (NP (NNP PBS))
              (PRN (-LRB- -LRB-)
                (NP (NNS controls))
                (-RRB- -RRB-)))))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VBZ means)
              (NP
                (NP (NNP ±) (NNP SEM))
                (: ;)
                (VP (VBN n)
                  (S
                    (VP (SYM =)
                      (NP (CD 6))))
                  (PP (IN for)
                    (NP (DT all) (NNS groups)))))))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (NNS Arrows))
    (VP (VBP show)
      (NP
        (NP (DT the) (NNS days))
        (PP (IN of)
          (NP
            (NP (NN treatment))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS days) (CD -1))
                (, ,)
                (NP (CD 0))
                (, ,)
                (NP (CD 3))
                (, ,)
                (NP (CD 6)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Treatment))
      (PP (IN with)
        (NP (NNP W3/25)
          (CC and)
          (NNP OX35))))
    (ADVP (RB significantly))
    (VP (VBD suppressed)
      (NP (NNP AA))
      (PP (IN from)
        (NP (NN day) (CD 13)))
      (PP (IN until)
        (NP (NN day) (CD 30))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (NNP RIB5/2))
    (VP
      (VP (VBD accelerated)
        (NP
          (NP (DT the) (NN onset))
          (PP (IN of)
            (NP (NNP AA))))
        (PP (IN by)
          (NP (CD 2) (NNS days))))
      (CC and)
      (VP (VBD led)
        (PP (TO to)
          (NP (JJ significant) (NN improvement)))
        (PP
          (ADVP (RB only))
          (IN in)
          (NP (DT the) (JJ late) (NN phase)))
        (PRN (-LRB- -LRB-)
          (PP (IN from)
            (NP (NN day) (CD 27)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP **) (NNP P))
    (VP (VBD ≤)
      (NP
        (NP
          (NP (CD 0.01))
          (, ,)
          (NP (NNP *) (NNP P) (NNP ≤) (CD 0.05))
          (, ,))
        (PP (IN in)
          (NP (NN comparison))))
      (PP (IN with)
        (NP (JJ PBS-treated) (NNS rats))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (NN representative))
      (PP (IN of)
        (NP (CD three) (NNS experiments))))
    (VP (VBZ is)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (ADVP (RB Supplementary))
    (PP
      (X
        (NP (NN Figure) (CD 1))
        (: :)
        (PP (IN In)
          (NP
            (NP (JJ vivo) (JJ delayed-type) (NN hypersensitivity))
            (PP (TO to)
              (NP
                (NP (NNP Mycobacterium) (NNP tuberculosis))
                (PP (IN on)
                  (NP (NN day) (CD 13))))))))
      (IN after)
      (S
        (NP
          (NP (JJ preventive) (NN treatment))
          (PP (IN of)
            (NP (NNP AA))))
        (, ,)
        (VP (VBG i.e.)
          (SBAR
            (WHADVP (WRB when))
            (S
              (NP
                (NP (DT the) (JJ clinical) (NNS differences))
                (PP (IN between)
                  (NP (DT the) (VBG accelerating)
                    (CC and)
                    (VBG ameliorating) (NN anti-CD4))))
              (VP (VBZ mAbs)))))))
    (VP (VBD were)
      (ADJP (JJ maximal)))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS data))
    (VP (VBP are)
      (VP (VBN expressed)
        (SBAR (IN as)
          (S
            (VP (VBZ means)
              (NP
                (NP (NNP ±) (NNP SEM))
                (PRN (-LRB- -LRB-)
                  (VP (VBN n)
                    (S
                      (VP (SYM =)
                        (NP (CD 6))))
                    (PP (IN for)
                      (NP (DT all) (NNS groups)))
                    (, ,)
                    (NP
                      (NP (CD one) (NN representative))
                      (PP (IN of)
                        (NP (CD three))))
                    (PP (IN in)
                      (NP (NN vivo) (NNS experiments))))
                  (-RRB- -RRB-))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN difference))
                    (PP (IN between)
                      (NP
                        (NP
                          (NP (DT the) (VBG swelling))
                          (PP (IN of)
                            (NP (DT the) (NN left)))
                          (PRN (-LRB- -LRB-)
                            (VP (VBN mycobacterium-treated))
                            (-RRB- -RRB-)))
                        (CC and)
                        (NP
                          (NP (DT the) (NN right))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP PBS-treated))
                            (-RRB- -RRB-))
                          (NP (NNS ears)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP *) (NNP P))
    (VP (VBD ≤)
      (NP (CD 0.05))
      (PP (IN in)
        (NP (NN comparison)))
      (PP (IN with)
        (NP (JJ PBS-treated) (NNS rats))))
    (. .)))

(ROOT
  (FRAG
    (X
      (ADVP (RB Supplementary))
      (NP (NN Figure) (CD 2)))
    (: :)
    (NP
      (NP
        (NP (NNP Concanavalin) (NNP A)
          (PRN (-LRB- -LRB-)
            (NP (NNP ConA))
            (-RRB- -RRB-))
          (NNP reactivity))
        (PP (IN of)
          (NP
            (NP
              (NP (JJ total) (JJ spleen) (NNP T) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN day) (CD 13))
                  (PP (IN of)
                    (NP (JJ adjuvant) (NN arthritis))))
                (-RRB- -RRB-)))
            (PP (IN from)
              (NP (NNS rats))))))
      (VP
        (ADVP (RB preventively))
        (VBN treated)
        (PP (IN with)
          (NP (JJ anti-CD4) (NNS mAbs)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Proliferation) (NNS data))
      (PP (IN from)
        (NP
          (NP (CD two) (JJ individual) (NNS animals))
          (PP (IN of)
            (NP (DT each) (NN treatment) (NN group))))))
    (VP (VBP are)
      (VP (VBN expressed)
        (SBAR (IN as)
          (S
            (VP (VBZ means)
              (NP
                (NP (NNP ±) (NNP SEM))
                (PP (IN of)
                  (NP (JJ triplicate) (NNS cultures))))
              (PP (IN from)
                (NP
                  (NP (CD one))
                  (PP (IN in)
                    (NP (NN vivo) (NN experiment))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ corresponding) (NN arthritis) (NN score))
      (PP (IN for)
        (NP (DT the) (NNS animals))))
    (VP (VBZ is)
      (VP (VBN shown)
        (PP (IN below)
          (NP (DT the) (NN graph)))))
    (. .)))

(ROOT
  (FRAG
    (X
      (ADVP (RB Supplementary))
      (NP (NN Figure) (CD 4)))
    (: :)
    (NP
      (NP
        (NP (NNP Mixed) (NN lymphocyte) (NN culture))
        (PP (IN of)
          (NP
            (NP (NN total))
            (PRN (-LRB- -LRB-)
              (X (SYM a))
              (-RRB- -RRB-))
            (CC and)
            (NP (NNP CD4) (NNP +))
            (PRN (-LRB- -LRB-)
              (X (SYM b))
              (-RRB- -RRB-)))))
      (VP (VBN spleen)
        (NP (NNP T) (NNS cells))
        (PP (IN from)
          (NP (JJ normal) (NNP Lewis) (NNS rats)))
        (PP (IN with)
          (NP
            (NP (JJ different) (NNS densities))
            (PP (IN of)
              (NP (JJ allogeneic)
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Wistar))
                    (: --)
                    (NP (NNP Prob)))
                  (-RRB- -RRB-))
                (JJ stimulator) (NNS cells) (, ,)
                (ADJP (JJ supplemented)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (JJ isotype) (NNS controls))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NNS IgG1))
                            (, ,)
                            (NP (NNS IgG2a)))
                          (-RRB- -RRB-)))
                      (, ,)
                      (CC or)
                      (NP
                        (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NN W3/25))
                        (, ,)
                        (NP (NNP OX35))
                        (, ,))
                      (CC and)
                      (NP
                        (QP (CD RIB5/2) (IN at) (CD 1))
                        (NN μg)))))
                (JJ /) (NNS ml)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Data))
    (VP (VBP are)
      (VP (VBN expressed)
        (SBAR (IN as)
          (S
            (VP (VBZ means)
              (NP
                (NP (NNP ±) (NNP SEM))
                (PP (IN of)
                  (NP (DT the) (JJ relative) (NN absorbance))))
              (PP (IN from)
                (NP
                  (NP
                    (NP (CD three) (JJ independent) (NNS experiments))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNS triplicates))
                        (PP (IN in)
                          (NP (DT each) (NN experiment))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (VP (VBN normalized)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN absorbance))
                        (PP (IN of)
                          (NP
                            (NP (JJ PBS-treated) (NNS cultures))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (QP (CD =) (CD 100))
                                (NN %))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP *) (NNP P))
      (VP (VBD ≤)
        (NP (CD 0.05))
        (PP (IN in)
          (NP (NN comparison)))
        (PP (IN with)
          (NP (DT the) (JJ respective) (NN isotype) (NN control)))
        (, ,)
        (S
          (VP (VBG #P)
            (NP (CD ≤) (CD 0.05))
            (PP (IN in)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (NNP W3/25)))))))))
    (, ,)
    (NP (NNP §) (NNP P))
    (VP (VBD ≤)
      (NP (CD 0.05))
      (PP (IN in)
        (NP (NN comparison)))
      (PP (IN with)
        (NP (NNP OX35))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NN Production))
      (PP (IN of)
        (S
          (VP
            (VP (VBG TNF-α)
              (PP (IN by)
                (NP (JJ spleen) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
              (PP (IN after)
                (NP (JJ anti-CD4) (NN preincubation)))
              (, ,)
              (SBAR (IN as)
                (S
                  (VP (VBN measured)
                    (PP (IN by)
                      (NP (NN bioassay)))))))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VBZ means)
                  (NP
                    (NP (NNP ±) (NNP SEM))
                    (PP (IN of)
                      (NP
                        (NP (CD three) (NNS experiments))
                        (: ;)
                        (VP (VBN pooled)
                          (NP (NNP T) (NNS cells))
                          (PP (IN from)
                            (NP
                              (NP (CD three) (JJ normal) (NNS rats))
                              (NP (DT each))))))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (VBG accelerating) (NN mAb))
      (, ,)
      (NP (NNP RIB5/2))
      (, ,))
    (VP (VBN induced)
      (NP
        (NP (DT a)
          (ADJP (RB significantly) (JJR stronger))
          (NN increase))
        (PP (IN of)
          (NP (JJ secreted) (NNS TNF-α))))
      (PP (IN than)
        (NP (DT the) (JJ other) (NNS mAbs))))
    (. .)))

(ROOT
  (S
    (NP (NNP Specificity))
    (VP (VBD was)
      (VP (VBN ensured)
        (PP (IN by)
          (S
            (VP (VBG adding)
              (NP (DT a) (JJ neutralizing) (JJ anti-TNF-α) (NN mAb))
              (PP (TO to)
                (NP
                  (NP (NNS supernatants))
                  (PP (IN from)
                    (NP (NN RIB5/2-treated) (NNS cultures))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP *) (NNP P))
      (VP (VBD ≤)
        (NP (CD 0.05))
        (PP (IN in)
          (NP (NN comparison)))
        (PP (IN with)
          (NP (DT the) (JJ isotype) (NN control)))
        (, ,)
        (S
          (VP (VBG #P)
            (NP (CD ≤) (CD 0.05))
            (PP (IN in)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (NNP W3/25)))))))))
    (, ,)
    (NP (NNP §) (NNP P))
    (VP (VBD ≤)
      (NP (CD 0.05))
      (PP (IN in)
        (NP (NN comparison)))
      (PP (IN with)
        (NP (NNP OX35))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP
        (NP
          (NP
            (NP (NNP Electromobility) (NN shift) (NN assay))
            (PRN (-LRB- -LRB-)
              (NP (NNP EMSA))
              (-RRB- -RRB-)))
          (PP (IN of)
            (NP
              (NP (JJ nuclear) (NNS extracts))
              (PP (IN from)
                (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))))))
        (PRN (-LRB- -LRB-)
          (VP
            (VP (VBN preincubated)
              (PP (IN with)
                (NP (JJ anti-CD4) (NNS mAbs))))
            (CC or)
            (VP (VBN stimulated)
              (PP (IN with)
                (NP (NNP PMA/ionomycin)))))
          (-RRB- -RRB-)))
      (PP (IN for)
        (NP
          (NP (NN AP-1))
          (PRN (-LRB- -LRB-)
            (X (SYM a))
            (-RRB- -RRB-))
          (CC and)
          (NP (NNP NF-κB))
          (PRN (-LRB- -LRB-)
            (X (SYM b))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (NN representative) (NN phosphoimage))
      (PP (IN of)
        (NP (CD three) (JJ independent) (NNS experiments))))
    (VP (VBZ is)
      (VP (VBN shown)
        (PRN (-LRB- -LRB-)
          (NP (JJ upper) (NNS panels))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Quantification))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS bands))
          (PP (IN of)
            (NP (DT all) (CD three) (NNS experiments))))))
    (VP (VBZ is)
      (VP (VBN shown)
        (ADVP (RB below))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VBZ means)
              (NP (NNP ±) (NNP SEM))))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT All) (CD three) (JJ anti-CD4) (NNS mAbs))
      (ADVP (RB slightly))
      (VP (VBD decreased)
        (NP (DT the) (NN AP-1) (NN activity))))
    (, ,)
    (CC and)
    (S
      (NP (NNP RIB5/2))
      (VP (VBN induced)
        (NP
          (NP (DT a) (JJ profound) (, ,) (JJ significant) (NN increase))
          (PP (IN of)
            (NP (JJ NF-κB) (NN activity))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP *) (NNP P))
      (VP (VBD ≤)
        (NP (CD 0.05))
        (PP (IN in)
          (NP (NN comparison)))
        (PP (IN with)
          (NP (DT the) (JJ isotype) (NN control)))
        (, ,)
        (S
          (VP (VBG #P)
            (NP (CD ≤) (CD 0.05))
            (PP (IN in)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (NNP W3/25)))))))))
    (, ,)
    (NP (NNP §) (NNP P))
    (VP (VBD ≤)
      (NP
        (NP
          (NP (CD 0.05))
          (PP (IN in)
            (NP
              (NP (NN comparison))
              (PP (IN with)
                (NP (NNP OX35))))))
        (, ,)
        (CC &)
        (NP
          (NP (NNP P) (NNP ≤) (NNP 0.05))
          (PP (IN in)
            (NP (NN comparison)))))
      (PP (IN with)
        (NP (NNP RIB5/2))))
    (. .)))

(ROOT
  (FRAG
    (X
      (ADVP (RB Supplementary))
      (NP (NN Figure) (CD 3)))
    (: :)
    (NP
      (NP
        (NP (NNP Concanavalin) (NNP A)
          (PRN (-LRB- -LRB-)
            (NP (NNP ConA))
            (-RRB- -RRB-))
          (NNP reactivity))
        (PRN (-LRB- -LRB-)
          (X (SYM a))
          (-RRB- -RRB-))
        (PP (IN of)
          (NP
            (NP
              (QP (CD CD4) (CD +))
              (NNP spleen) (NNP T) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN day) (CD 13))
                (PP (IN of)
                  (NP (JJ adjuvant) (NN arthritis))))
              (-RRB- -RRB-))))
        (PP (IN from)
          (NP (NN preventively))))
      (VP (VBN treated)
        (NP (NNS rats))
        (PP (IN with)
          (NP (JJ anti-CD4) (NNS mAbs)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Proliferation) (NNS data))
      (PP (IN from)
        (NP
          (NP (CD two) (JJ individual) (NNS animals))
          (PP (IN of)
            (NP (DT each) (NN group))))))
    (VP (VBP are)
      (VP (VBN expressed)
        (SBAR (IN as)
          (S
            (VP (VBZ means)
              (NP
                (NP (NNP ±) (NNP SEM))
                (PP (IN of)
                  (NP (JJ triplicate) (NNS cultures)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ corresponding) (NN arthritis) (NN score))
      (PP (IN for)
        (NP (DT the) (NNS animals))))
    (VP (VBZ is)
      (VP (VBN shown)
        (PP (IN in)
          (NP (DT the) (NN middle)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN correlation))
      (PP (IN between)
        (NP
          (NP
            (NP (NN reactivity))
            (PP (TO to)
              (NP (NNP ConA))))
          (CC and)
          (NP
            (NP (DT the) (NN severity))
            (PP (IN of)
              (NP (NN arthritis)))))))
    (VP (VBZ is)
      (VP (VBN shown)
        (PP (IN in)
          (PRN (-LRB- -LRB-)
            (NP (NNP b))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Normals))
    (VP (SYM =)
      (NP (JJ normal) (, ,) (JJ untreated) (NNS rats)))
    (. .)))

(ROOT
  (FRAG
    (FRAG
      (ADVP (RB Supplementary))
      (NP (CD Figure) (CD 5)))
    (: :)
    (FRAG
      (NP
        (NP (NN Production))
        (PP (IN of)
          (NP
            (NP
              (NP (NNP IFN-γ))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (SYM a))
                  (, ,)
                  (NP (SYM b))
                  (, ,)
                  (NP (SYM c)))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN IL-4))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (SYM d))
                  (, ,)
                  (NP (NNP e))
                  (, ,)
                  (NP (SYM f)))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN IL-10))
              (PRN (-LRB- -LRB-)
                (NP (NN g) (, ,) (NN h) (, ,) (NN i))
                (-RRB- -RRB-))))))
      (PP (IN by)
        (NP (JJ spleen) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
      (PP (IN after)
        (ADJP (JJ anti-CD4-preincubation))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Percentage))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ cytokine-positive) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (JJ upper) (NNS panels))
              (-RRB- -RRB-)))
          (, ,)
          (NP (PRP$ their) (JJ mean) (JJ fluorescence) (NN intensity))))
      (PRN (-LRB- -LRB-)
        (NP (NNP MFI))
        (-RRB- -RRB-))
      (PP (IN after)
        (NP
          (NP (NN intracellular) (NN staining))
          (PRN (-LRB- -LRB-)
            (NP (JJ middle) (NNS panels))
            (-RRB- -RRB-))
          (, ,)
          (CC and)
          (NP
            (NP
              (NP (NN secretion))
              (PP (IN of)
                (NP
                  (NP (DT the)
                    (ADJP (JJ cytokine)
                      (PP (IN into)
                        (NP (NN cell) (NN culture))))
                    (NN supernatant) (RB as))
                  (VP (VBN measured)
                    (PP (IN by)
                      (NP (NNP ELISA)))))))
            (-LRB- -LRB-)
            (NP (JJR lower) (NNS panels))
            (-RRB- -RRB-))
          (, ,)
          (VP (VBN shown)
            (PP (IN as))))))
    (VP (VBZ means)
      (NP
        (NP (NNP ±) (NNP SEM))
        (PP (IN of)
          (NP
            (NP (CD three) (JJ independent) (NNS experiments))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (JJ triplicate) (NNS determinations))
                (PP (IN in)
                  (NP
                    (NP (JJ pooled) (NNS cells))
                    (PP (IN from)
                      (NP
                        (NP (CD three) (JJ normal) (NNS rats))
                        (PP (IN in)
                          (NP (DT each) (NN experiment))))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP *) (NNP P))
      (VP (VBD ≤)
        (NP (CD 0.05))
        (PP (IN in)
          (NP (NN comparison)))
        (PP (IN with)
          (NP (JJ isotype) (NN control)))
        (, ,)
        (S
          (VP (VBG #P)
            (NP (CD ≤) (CD 0.05))
            (PP (IN in)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (NNP W3/25)))))))))
    (, ,)
    (NP (NNP §) (NNP P))
    (VP (VBD ≤)
      (NP
        (NP
          (NP (CD 0.05))
          (PP (IN in)
            (NP
              (NP (NN comparison))
              (PP (IN with)
                (NP (NNP OX35))))))
        (, ,)
        (CC &)
        (NP
          (NP (NNP P) (NNP ≤) (NNP 0.05))
          (PP (IN in)
            (NP (NN comparison)))))
      (PP (IN with)
        (NP (NNP RIB5/2))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (NN key))
        (PP (TO to)
          (NP (NNS bars)))))
    (, ,)
    (VP (VB see)
      (NP (NNP Supplementary) (NNP Figure) (CD 4)))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP Supplementary) (NNP Table))
      (NP (CD 1)))
    (: :)
    (NP
      (NP (NNP Affinity) (NNS data))
      (PP (IN of)
        (NP (DT the) (JJ anti-CD4) (NN mAb) (NNP Supplementary) (NNP Table) (CD 2))))
    (: :)
    (NP
      (NP (JJ Cytofluorometric) (NNS analyses))
      (PP (IN of)
        (NP
          (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
          (PP (IN on)
            (NP
              (NP (NN day) (CD 8))
              (PRN (-LRB- -LRB-)
                (NP (NNP A))
                (-RRB- -RRB-))
              (CC and)
              (NP (NN day) (CD 13))
              (PRN (-LRB- -LRB-)
                (NP (NNP B))
                (-RRB- -RRB-))))))
      (PP (IN of)
        (NP
          (NP (JJ anti-CD4) (NN treatment))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNS data))
              (PP (IN from)
                (NP
                  (NP (CD one) (NN representative))
                  (PP (IN of)
                    (NP (CD three)))))
              (PP (IN in)
                (NP (NN vivo) (NNS experiments))))
            (-RRB- -RRB-)))))
    (. .)))

